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Abstract 
 
Background 
Despite the recognition that psychosocial interventions can improve quality of life and 
mental health, there continues to be a lack of clarity and guidance around effective 
psychosocial interventions for children and young people with epilepsy.  This review 
utilises specific quality criteria to systematically identify and appraise the evidence for the 
effectiveness of psychosocial interventions for children and young people with epilepsy.  
 
Methods 
A systematic search of six electronic databases was conducted using predefined eligibility 
criteria. The reference lists of previous review papers were also manually searched. 
Seventeen studies met the inclusion and exclusion criteria. A quality appraisal checklist, 
the ‘Crowe Critical Appraisal Tool’ (CCAT) [1] was applied to the included articles and 
effect sizes were calculated when not provided in the papers.  
 
Results 
Methodological quality of the majority of studies included was moderate, with only three 
studies rated as high quality. Meta-analysis was not conducted as the studies used 
heterogeneous methodologies and lacked consistency in outcome measures. Limited 
evidence was found for interventions improving epilepsy knowledge, quality of life and 
psychological outcomes. 
 
Conclusions 
Psychosocial interventions may provide clinical benefit although further research is 
needed to clarify the most effective treatment components, delivery methods and 
measurement of intervention outcomes. The existing evidence base for children and 
young people is limited by methodological issues such as the use of small samples, 
inadequate power and a lack of controlled studies.  
 
Keywords: psychosocial; intervention; treatment; epilepsy; children; adolescents 
Word Count: 8,689
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1. Introduction 
 
Epilepsy is the most common neurological disorder in children under 18 years of age in 
the UK [2] and is defined by the presence of recurrent seizures, resulting from abnormal 
electrical activity in the nerve cells of the cerebral cortex. Approximately 63,400 children 
and young people aged 18 years and under in the UK have a diagnosis of epilepsy and 
take anti-epileptic drugs (AED), equivalent to approximately 1 in 220 children [3].  
 
Epilepsy is known to be associated with a range of psychosocial difficulties and cognitive 
deficits. Baker et al. [4] highlighted that although strong correlations have been found 
between epilepsy and depression in adolescents, mental health problems are under-
diagnosed and undertreated in this population. Children with epilepsy have been found to 
be almost five times more likely to have behavioural problems than healthy controls [5]. 
Dunn et al. [6] reported younger age at onset of seizures, a lower socioeconomic status 
and family stress as predictors of behavioural problems in children and young people with 
epilepsy (CYPE). Neuropsychological assessment and parental questionnaires within the 
first year of diagnosis have demonstrated that significantly more children with epilepsy 
require special educational assistance than matched classmate controls [7]. Children with 
epilepsy also obtained worse scores in behavioural and cognitive domains. 
 
Given the potential for psychosocial difficulties related to epilepsy, the impact on quality 
of life (QoL) has been researched. In adult studies, depression and anxiety were found to 
explain more variance in QoL than seizure control/frequency or demographic variables [8, 
9]. In Baker et al.’s [10] international questionnaire study, more than one third of CYPE 
who responded expected the condition to hinder their lives in the future, with 36% 
keeping their epilepsy a secret from others from fear of being treated differently. Taylor 
et al. [11] found that when compared to healthy children and children with asthma, 
children with newly diagnosed epilepsy had significantly poorer QoL across multiple 
domains. QoL was significantly poorer in children with new-onset epilepsy. It also noted 
that parents of children with epilepsy reported reduced QoL. They suggest that QoL could 
be improved in adolescents with newly diagnosed epilepsy through psychosocial 
interventions focussed on increasing self-esteem [11]. Involvement of parents in these 
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interventions was also advocated to maintain healthy and positive parent-child 
relationships. The literature indicates that both psychosocial and seizure factors impact 
on the wellbeing of CYPE, and that cognitive and academic functioning and psychosocial 
adjustment can be negatively impacted by epilepsy, underlining the need for early  
Dunn et al. [6] found that children with a more positive response and attitude towards 
illness and increased sense of control over their epilepsy reduced their risk of developing 
behavioural problems, depression and poor self-concept. Oostrom et al. [7] reported that 
epilepsy syndrome, use of AED and seizure control were not significantly related to the 
cognitive or behavioural findings. Rather, the child's pre-diagnostic learning and 
behavioural histories and the parents' ability to continue their habitual parenting post-
epilepsy diagnosis were associated with cognitive and behavioural functioning [12]. 
However, Hermann et al. [13] found that inadequate seizure control (frequency and 
severity) was the best predictor of behavioural problems in 6-11 year old children. Much 
of the literature has used self and carer-reported QoL via standardised questionnaires, 
but some have used qualitative techniques to develop a better understanding of the 
issues and concerns directly expressed by CYPE [14, 15]. These studies have used the 
young people’s own perspectives to develop a biopsychosocial model of the impact of 
epilepsy on the lives of young people and have been used to develop psychosocial 
interventions. 
 
The recent NICE guideline on the management of epilepsy promotes the consideration of 
the physical, psychological and social needs of CYPE by healthcare professionals, 
highlighting that particular attention should be paid to their relationships with family and 
friends, and at school [16]. It is recommended that CYPE should be given information on 
general issues with epilepsy, ranging from treatment options to the impact on lifestyle 
e.g. effects of sleep deprivation [16].  
 
Within the last fifteen years, research developing psychosocial interventions for CYPE has 
increased, with the majority using group educational programs and cognitive and 
behavioural interventions. Several literature reviews have been carried out in this area in 
the past ten years but often they do not meet the requirements of a systematic review 
[17-19]. The focus of most has been on adult populations, although two do include child 
and adolescent studies [20, 21]. A more recent Cochrane systematic review examined the 
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effectiveness of specialist service models for children with epilepsy and their families [22]. 
Although the Cochrane paper reviewed some of the studies that will be included in the 
current review, it focussed on comparing the effectiveness of specialist teams/individuals 
in the care of children with epilepsy with usual care services and only included controlled 
studies.  It was therefore considered timely to review the literature on psychosocial 
interventions for CYPE, incorporating a wider range of methodologies and also including 
studies published since 2010. This systematic review aims to synthesise and analyse the 
research that investigates psychosocial interventions for CYPE. In addition to a summary 
of study findings, it will critically assess the quality of the evidence. An evaluation of the 
literature will help determine the effectiveness of interventions for CYPE and may help to 
develop guidelines on their use. 
 
For the purpose of this review a psychosocial intervention is defined as a therapeutic 
intervention without a pharmacalogical component focusing on psychological, relational 
and social functioning. They can include formal psychological interventions e.g. CBT and 
health education-based programmes, as well as those with an emphasis on developing 
social interaction skills. Interventions with a physical exercise content can also be 
considered under this definition if the aims are related to improving psychosocial 
wellbeing through physical activity and the associated physical and social benefits. 
 
1.1 Research Aims 
 
1. To establish if there is any evidence for the efficacy of psychosocial interventions for 
CYPE. 
 
2. To identify specific treatment components or methods of delivery that may increase 
the efficacy of these interventions. 
 
3. To identify intervention goals and how these measured. 
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2. Method 
 
The PRISMA statement [23] was used as guidance for the undertaking and reporting of 
this systematic review.  
 
2.1 Search Strategy 
 
The following electronic databases were systematically searched on 28th November 2014 
to identify studies: CINAHL, PsychInfo, Psychology & Behavioral Sciences Collection (via 
EBSCO host); Embase, Medline (via OVID online); and Web of Science (via Web of 
Knowledge).  
 
The following search terms were used, both as key words and as Medical Subject 
Headings (MeSH), creating four search strings (using the Boolean operators ‘OR’ to 
combine searches within strings and ‘AND’ to combine search strings). 
 
Exp Epilepsy OR Epilep* 
AND 
Psychosocial OR Psychoeducation* OR Psycholog* OR Psychotherap* OR Exp 
 Psychotherapy  
  AND  
Interven* OR Treat* OR Therap* 
*signifies truncations or possible extra letters in the term to be included within 
the search. ‘Exp’ indicates the term was exploded.  
 
Searches were limited to those published in English with human subjects. An age limit 
was not set as this could have excluded some studies meeting inclusion criteria. Hand 
searches were also carried out on reference lists of 7 review papers in addition to the 
electronic search [17-22, 24]. Duplicate entries were removed. Where more than one 
paper reported on the same participant sample within the same follow-up timeframe, all 
papers were selected for inclusion. The following selection criteria were applied. Inclusion 
criteria: (1) Studies published in English from any country; (2) Studies published in peer 
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reviewed journals; (3) Studies published between 1989 and 2014; (4) Studies describing 
original data; (5) Studies including children and young people aged 0-19 years with a 
diagnosis of any type of epilepsy1. Exclusion criteria: (1) Drug/animal studies; (2) Studies 
including participants without an epilepsy diagnosis; (3) Studies including participants 
with learning disabilities; (4) Studies including children and adolescents within an adult 
population (5) Studies with a ketogenic diet as the sole content. The following categories 
of article were also excluded: case studies, qualitative studies, book sections, systematic 
reviews, literature reviews, meta-analyses, dissertations, conference 
presentations/abstracts, guidelines, and commentaries. 
 
 
2.2 Quality Assessment  
 
The Crowe Critical Appraisal Tool [CCAT, version 1.4] [1] was used to assess the quality of 
included studies (Appendix 1.2). The CCAT was developed from a critical review of 
existing critical appraisal tools and based on general research methods theory and 
reporting guidelines. It was specifically designed for systematic reviews which want to 
include information from a variety of quantitative and qualitative health research designs. 
The CCAT can be used to assess the quality of the reporting of the research in addition to 
comprehensively assessing the research studies. The results obtained from using the 
CCAT have undergone evaluation for validity and reliability testing to verify those results. 
A user guide is provided to be used along with the CCAT to maintain reliability. The CCAT 
contains 22 items within 8 categories which are rated on a scale of 'Present', 'Absent' or 
Not Applicable'. A score out of 5 is given for each category with 40 being the maximum 
achievable total score. Scores were converted into percentages and as the CCAT does not 
include qualitative descriptions of scores, the following categories were assigned to allow 
for comparison: Poor Quality (≤50%); Acceptable Quality (51-74%); High Quality (≥75%).  
 
                                                            
1 In the UK child and adolescent health services typically provide care for children up to age 18 (or age 16 in 
some paediatric hospital settings). The age of adolescence is currently debated in regards to brain and 
social development, with some now arguing it continues into a person’s twenties [52, 53]. However, it was 
decided that this review would use the World Health Organization and UNICEF's definition of adolescence 
of any person between ages 10 and 19 years. A participant age range from 0-19 years was therefore set 
[54].    
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3. Results 
 
3.1 Search Results 
 
The study selection process is detailed in Figure 1. Electronic searches initially returned 
3177 articles reduced to 2231 once duplicate articles were removed. These 2231 articles 
were examined on the basis of title and abstract according to the inclusion and exclusion 
criteria, which led to the rejection of 2160 articles. Full text journal articles were sourced 
for the remaining 71 articles, along with 11 additional articles identified through seven 
review papers [17-22, 24]. This resulted in the exclusion of a further 59 articles. Two 
studies were reported across two articles [25-28] and two across three [29-34], resulting 
in a total of 17 studies, reported in 23 articles eligible for inclusion in this review.  
 
3.2 Quality Rating Results 
 
All 17 studies were rated by the author and an independent reviewer using the CCAT 
quality rating scale. Full agreement was achieved on the majority of papers (14 out of 17; 
82%) initially. Disagreements were resolved by discussion leading to 100% inter-rater 
agreement. Ratings of study quality for each paper are provided in Appendix 1.3. Only 
three studies were rated as high quality [32-36], three were poor quality [37-39] and the 
rest were of acceptable quality [25-31, 40-47].  
 
3.3 Data Extraction 
 
Table 1 presents a summary of the relevant information from all 17 studies. This includes 
sample characteristics, design, intervention delivery method, outcome measures used, 
data analysis, the key significant findings of the studies and calculated effect sizes.  
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Figure 1: Flow diagram of study selection process 
 
3.3.1 Sample size 
With the exception of two studies [25, 26, 35] all of the papers had sample sizes <100 
participants. Only one study [35] explicitly reported a power calculation. Twelve of the 
studies had sample sizes of 30 or fewer participants, demonstrating the challenges of 
recruiting large samples to psychosocial intervention studies. Such small samples meant 
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that many of the studies called for replication of their research with larger samples to 
establish the validity and generalisability of their findings. The design of many of the 
studies also restricted the strength of the conclusions that could be drawn from the 
outcomes. Only seven of the seventeen studies included control groups [25, 26, 29, 30, 
31, 35, 36, 43, 44, 47], two of which were not randomised [29, 30, 31 35].  
 
3.3.2 Effect size 
Notably, only two studies [29, 30, 31, 35] in this review reported effect sizes and even in 
these cases they were not calculated for every outcome. Effect sizes were therefore 
calculated for papers providing the required data (means and standard deviations) (Table 
1). Cohen’s d [48] was used for studies which had a sample size of 30 participants or more  
[29, 30, 31, 35, 40, 42, 47] and for those with less [27-29, 32-34, 36-38, 41, 43, 45], 
Hedge's g was used to calculate effect size to provide a more accurate estimate [49]. 
Hedges’ g is a variation of Cohen's d that corrects for and is less susceptible to potential 
sources of bias due to small sample sizes [50]. The magnitude of Hedges’ g may be 
interpreted using Cohen's convention as small (0.2), medium (0.5), and large (0.8) [48]. 
Effect sizes could not be calculated for two studies with insufficient data [25, 26, 44] and 
only partially for another article [47].  
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Table 1 Summary of Studies  
Study Sample Design Intervention 
Delivery 
Outcome               
Measures           
a See appendix 
1.4 for full 
outcome 
measures and 
references 
Analysis Main Findings – significant 
results and Effect Sizes 
* Effect sizes not reported in 
paper, calculated where 
possible.  
Austin et al. 
(2002) 'Be 
Seizure Smart' 
 
 
9 children aged 
7-13 years in 10 
families (8 
mothers, 2 
fathers, 1 
grandmother, 4 
siblings).  
 
Epilepsy 
duration: 
>2months, 
<12months.  
 
USA. 
One group, 
pre-test/post-
test (2 weeks 
prior to 
intervention 
and 2 week 
follow-up). 
 
Five family tailored 
educational 
telephone 
interviews plus 
postal information 
delivered by a 
nurse over 3-4 
months.  
Authors-
designed parent 
and child 
questionnaires 
(general 
concerns, fears 
of epilepsy, 
seizure 
management, 
epilepsy 
knowledge). 
PCS. 
CATIS. 
APGAR.  
Paired t-tests.  * 
Significantly lower epilepsy 
concerns (g =0.15) and less 
need for information (g 
=0.76) and significantly higher 
general knowledge about 
epilepsy (g=1.60) and better 
family functioning (g=0.95) 
from baseline to 2 week 
follow-up.  
 
Parents: Significantly greater 
knowledge about seizures 
(g=0.62) and significantly less 
need for information (g=1.79) 
and support (g=1.25) from 
baseline to 2 week follow up.  
Blocher et al. 
(2012, 2013) & 
Jones et al. 
15 children 
aged 8-13 years.  
 
One group, 
pre-test/post-
test (baseline, 
Manualised 
computer assisted 
CBT delivered in 
SCARED.  
MASC. 
CDI. 
Repeated-
measures one-
way ANOVAS. 
* 
Significant reduction in 
anxiety SCARED-C (g=0.88), 
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(2014) 'Camp 
Cope-A-Lot' 
Epilepsy 
duration:> 6 
months. 
 
Met DSM-IV 
criteria for an 
anxiety 
disorder. 
 
USA. 
final session 
and 3 month 
follow up). 
presence of 
therapist in a 
medical centre.12 
weekly 50-60 
minute sessions. 
Parents met with 
child's therapist for 
4 sessions and at 
follow up.  
CBCL. 
PH-1.  
 
MASC (g=0.70), depression 
CDI (g=0.54), and problem 
behaviours CBCL (g=0.38) 
from baseline to 3 month 
follow up. 
 
 
Conant et al. 
(2008) Karate 
program 
 
 
11 children 
aged 8-16 years 
(data only 
available for 9). 
 
Epilepsy 
duration: 
> 1year.  
 
USA. 
One group, 
pre-test/post-
test (week 1 
and final 
session). 
Group karate 
program for 10 
weekly 1 hour 
sessions.   
PH1. 
QOLCE. 
PSI/SF. 
 
Wilcoxon 
signed-rank 
test.  
* 
Significant increase in 
memory subscale of parent's 
perception of child's QoL 
(g=0.76) from between week 
1 and week 10 of 
intervention.   
Carbone et al. 
(2014) Group 
CBT 
 
 
34 adolescents 
aged 13-17 
years. 
 
Epilepsy 
duration: not 
specified. 
 
One group, 
pre-test/post-
test (baseline, 
final session 
and 4 month 
follow up). 
Group CBT 
delivered by social 
workers and one 
study author. 
Either one-day 6 
hour workshop or 6 
weekly 1 hour 
sessions of online 
SDQ.  
 
 
  
Repeated-
measures 
ANOVA for 
child SDQ 
scores. Paired t-
tests for parent 
SDQ scores.   
* 
Intervention delivery 
methods (workshop and 
online) were analysed 
together due to small sample 
size.  
 
Adolescents reported a 
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USA.  group via 
videoconferencing 
and instant 
messaging.  
significant increase in pro-
social behaviour (d=2.37) 
from baseline to 4 month 
follow up. 
 
Parents scores significantly 
improved from baseline to 4 
month follow up in: total 
difficulties (d=1.94), impact 
(d=4.50), peer problems 
(d=2.22) and pro-social 
behaviour (d=2.05).  
Eom et al. (2014) 
Exercise therapy 
 
10 children 
aged 8-12 years. 
 
Epilepsy 
duration: 
not specified. 
 
Republic of 
Korea. 
One group, 
pre-test/post-
test (baseline 
and final 
session). 
Exercise group 
intervention, 3 
hour sessions twice 
weekly for 5 weeks, 
delivered by an 
exercise therapist 
plus home practice.  
Separate parents 
exercise education 
programme.   
 
WISC-III 
CAT 
CCTT 
CDI-K 
RCMAS 
K-QOLCE 
K-CBCL 
Wilcoxon 
signed rank 
test.  
* 
Significant improvement in 
visual (g=0.87) and auditory 
attention (g=0.47) on the 
CAT, executive function index 
CCTT2 (g=0.92), internalizing 
behaviour problems (g=1.85) 
and social problems (g=0.37) 
on the CBCL, and well-being 
(mood) (g=0.55) on the K-
QOLCE from baseline to week 
five.  
 Frizzell et al. 
(2011) Education 
intervention 
 
30 adolescents 
aged 12-19 
years. 
 
One group, 
pre-test/post-
test (baseline 
and 1 month 
Education based, 1 
individual 2 hour 
session and 1 
group 2 hour 
Self-knowledge 
of epilepsy 
AKEQ  
SSES-C 
Paired t-tests. * 
Significant improvement in 
self-knowledge (d= 2.60), 
general epilepsy knowledge 
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Epilepsy 
duration: >12 
months.  
 
Australia. 
follow up). session 1-3 months 
later.   
CATIS 
RSES 
AKEQ (d=1.77), attitude 
towards illness CATIS (d=0.33) 
and self-efficacy SSES-C 
(d=0.42) from baseline to 1 
month follow up. 
 
Glueckauf et al. 
(2002)Family 
counselling 
 
 
22 adolescents 
aged 12-19 
years and 21 
mothers, 15 
fathers. 
 
5 in video-
conferencing 
group, 4 in 
speakerphone 
group, 6 in 
office group and 
7 wait list 
control group. 
 
Epilepsy 
duration: not 
specified. 
 
USA.   
RCT - 3 arm 
(baseline, 1 
week post-
intervention 
and 6 month 
follow-up). 
Family counselling 
delivered via either 
video-
conferencing, 
speakerphone or 
face-to-face. 6 
fortnightly 90-120 
minute sessions.  
 
 
 
ISS 
IFS 
ICS 
SSRS  
WAI 
Proportion of 
outside 
assignments 
completed 
Number of 
missed 
appointments.  
MANOVA 
followed by 
univariate 
ANOVA 
ANOVA and 
Chi² test.  
* 
Data for wait list control 
group not reported 
 
Significant reduction in 
problem severity ISS (g=2.07) 
and frequency IFS (g=1.53) 
from baseline to 6 month 
follow up for all 3 
intervention groups 
combined. 
 
Significant improvements in 
parental report of pro-social 
behaviour from baseline to 1 
week post-intervention were 
not maintained at 6 month 
follow up for all 3 
intervention groups 
combined.  
   
 Jantzen et al. 135 8-16 year Pre-test/post- Group psycho- EKP-G Repeated- ES reported.  
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(2009) ‘Flip & 
Flap’ 
 
 
olds. 65 in 
intervention 
group (IG) plus 
72 parents.  
70 Controls 
(WCG) plus 
72 parents.  
 
Epilepsy 
duration: not 
specified. 
 
Germany.  
 
test non-
randomised 
control group 
(baseline and 6 
month follow 
up).  
 
Control group 
6 months 
before 
intervention 
and just before 
receiving 
intervention.  
educational 
programme for 
either 2 days 
(14 hours) or 2.5 
days (16 hours). 
Separate groups 
for children (8-
11years), 
adolescents (12-16 
years) and parents.  
Delivered by a 
doctor and 
psychologist for 
parents and 
delivered by 
various health care 
professionals/social 
workers to 
children.  
 
Waiting list control 
group.  
 
 
EKP 27 
HRQOL 
ZUF-8 
Parental report 
of child self-
management 
skills 
Parental 
epilepsy-related 
worries 
Disclosure of 
epilepsy to 
others 
 
 
measures 
Univariate 
ANOVA, Chi²-
test, Mann-
Whitney test 
and t-test.  
 
Significant time-by-group 
effect of increased self-
management skills (d=0.6) 
and decreased direct carer 
control (d=0.7) and increased 
independence in their child’s 
social activities (d=0.8) for IG 
compared with WCG.  
 
Significant time-by-group 
effect of increase in QoL on 
social exclusion scale (d=0.3).  
 
Significant time-by-group 
effect for parental report of 
decrease in epilepsy-related 
worries (d = 0.5). 
 
Significant increase in 
epilepsy knowledge for 
children, adolescents and 
parents from baseline to 6 
month follow up in treatment 
group compared to control 
group (d = 0.6–1.4). 
 Lewis et al. 
(1990, 
236 children 
aged 7-14. 123 
Pre-test/post-
test control 
Family educational 
programme. 4 
Harter’s Self 
Competency 
Chi² test.  * Data not available to 
calculate ES.  
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1991)Educational 
programme 
 
 
in treatment 
group 113 in 
control. 365 
Parents 
attended 
separately. 
 
Epilepsy 
duration: not 
specified  
 
Chile.  
group 
(baseline and 5 
month follow 
up).  
weekly 90 minute 
sessions of child 
groups delivered by 
teacher and parent 
groups by a social 
worker.  
 
Control group 
attended three 2 
hour sessions of 
lectures delivered 
by a physician 
covering same 
content as 
intervention group.  
Scale 
Interview on 
medical, social 
history, 
knowledge of 
epilepsy and 
self-
competency.   
 
Treatment group 
demonstrated a significant 
increase in half of the 
epilepsy knowledge items at 
5 month follow up and 
compared to control group.  
 
Significant decrease in 
parental anxiety compared to 
controls at 5 month follow 
up.  
Martinovic et al. 
(2006) CBT for 
depression 
 
 
30 adolescents 
aged 13-19 
years with sub-
threshold 
depression 
assigned to 
intervention 
(CBI) or TAU 
groups.  
 
Epilepsy 
duration  
≤ 12 months. 
RCT (baseline 
and 6 and 9 
month follow 
ups). 
 
 
Individual Cognitive 
behavioural 
intervention (CBI) 
administered by 
two of study 
authors for 8 
fortnightly sessions 
then 4 monthly 
sessions.  
 
TAU was 
therapeutic 
counselling without 
BDI 
HAMD 
CES-D 
QOLIE-31 
Repeated-
measures 
ANOVA, 
Pearson 
correlation, 
Chi2 test, Wald 
Wolfowitz run 
test.  
* 
Significant in reduction in 
depression BDI (g=0.85) CES-
D (g=0.69) and increase in 
QoL QOLIE-31 (g=-1.79) in CBI 
group compared to TAU 
group at 9 month follow up. 
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Serbia.  
CBI. 
Modi et al. 
(2013) Education 
intervention 
 
 
8 children aged 
2-12 years 
assigned to 
intervention or 
TAU groups.  
19 in 'near 
perfect 
adherence 
group' 
Plus families.  
 
Epilepsy 
duration: ≤ 7 
months 
 
USA. 
RCT pilot 
(baseline and 
final session). 
Family education 
and problem 
solving skills 
intervention for 4 
fortnightly 
sessions, ranging 
over 3-4 months.  
MEMS'TrackCap'  
FAQ 
Descriptive 
statistics and 
qualitative data 
from 
questionnaires.  
*Data not available to 
calculate ES. 
 
2 families had large 
improvements in AED 
adherence rates but had low 
baseline rates.  
 Rau et al. 
(2006), Wohlrab 
et al. (2007) & 
Pfafflin et al. 
(2012) FAMOSES 
 
 
50 children 
aged 7-13 years, 
and 103 parents 
were assigned 
to intervention 
or waiting list 
control group. 
 
Epilepsy 
duration: 
Pre-test/post-
test non-
randomised 
control group 
(baseline and 3 
month follow 
up and 5 year 
follow up with 
parents only).  
Education 
programme for 7 
60-90 minute 
sessions for 
children and 6 
sessions for 
parents, delivered 
by a physician and 
psychologist. 
Delivered either 1 
KINDL 
School 
attendance 
Seizure 
frequency 
Specifically 
designed 
questionnaire 
on epilepsy 
knowledge, 
MANOVA 
ANOVA 
Wilcoxon 
signed rank 
test. 
ES reported. 
 
Significant improvements 
reported by children in social 
restrictions in daily life for 
intervention group compared 
to controls at 3 month follow 
up (d=-0.58) 
 
Significant improvements 
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Not specified 
 
Germany.  
session per day in 
inpatient settings, 
and weekly or over 
a weekend for 
outpatients.  
coping, 
adaptation, 
restrictions in 
daily living, 
anxiety  
 
reported by parents in the 
intervention group compared 
to control group at 3 month 
follow up in the following 
areas: epilepsy knowledge 
(d=1.20); adaptation (d=0.46); 
epilepsy-related anxiety (d=-
0.29); attendance to rules 
(d=-0.42) and seizure 
management (d=0.41) 
 Shore at al. 
(2008) SEE 
Program 
 
 
11 Children 
aged 13-18 
years in 13 
families. 
 
Epilepsy 
duration: not 
specified 
 
USA. 
 
One group, 
pre-test/post-
test (baseline 
and 1 month 
and 6 months 
follow ups).  
 
Parent and child 
education sessions. 
Two 8 hour 
sessions over a 
weekend 
delivered by 
program developer 
(not author of 
paper). 
CHQ 
MAACL 
CDI 
PCS 
Parent response 
to illness scale 
SSES 
Knowledge 
related to 
epilepsy scale  
T-tests, 
Repeated-
measures 
ANCOVA 
 
* 
Significant improvement in 
child self-report of QoL from 
baseline to 6 month follow up 
on the following domains: 
Mental health (g=0.69); 
behaviour (g=0.59); self-
esteem (g=0.78) and in 
depression scores CDI 
(g=0.69).  
 
There were also significant 
improvements in parental 
report of child’s QoL.  
Snead et al. 
(2004) ‘Taking 
Charge of 
Epilepsy’ 
7 adolescents 
aged 13-18 
years and at 
least one 
One group, 
pre-test/post-
test (baseline 
and final 
Group 
psychoeducation 
intervention for 6 
weekly 1-hour 
QOLIE-AD-48 
CDI 
RCMAS 
Paired t-test, 
Chi² test, 
descriptive 
qualitative 
* 
No quantitative results 
reached significance.  
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parent.  
 
Epilepsy 
duration: 
>1 seizure in 
last 24 months 
 
USA. 
session).   
 
sessions delivered 
by clinical 
psychology interns. 
Separate 
adolescent and 
parent groups.  
 
data.   
Stafstrom et al. 
(2012) Art 
therapy  
 
 
16 children 
aged 7-18 years. 
 
Epilepsy 
duration: 
>6 months 
 
 USA. 
One group, 
pre-test/post-
test (baseline 
and no details 
provided of 
post-test).  
Art therapy focus 
groups. Four 90 
minute groups over 
1 month 
CATIS Not stated, 
presumed t-
test.  
* 
No quantitative results 
reached significance.  
 
Tieffenberg et al. 
(2000) ‘Acindes’ 
 
 
99 children 
aged 7-12 years, 
54 in treatment 
group, 45 in 
control group 
plus parents.  
 
Epilepsy 
duration: 
> 5 months 
 
Argentina 
Randomised 
field trial – 
pre-test/-post-
test control 
group 
(baseline and 6 
and 12 month 
follow ups).  
Group play-based 
educational 
intervention with 
separate sessions 
for children and 
parents. 5 weekly 2 
hour meetings 
followed by a 
reinforcement 
meeting 2-6 
months later, 
facilitated by 
CHLCS  
Parent and Child 
Survey – 
sociocultural 
School 
Absenteeism 
Clinical 
Variables.  
Duncan test of 
multiple 
comparisons, 
Mann-Whitney 
U test, 
Wilcoxon 
signed rank 
test, 
Probability of 
Gain test.  
*  
Significant increase in 
children's internal locus of 
control, significant decrease 
in school absenteeism, 
seizures (d= -0.08) and 
emergency hospital visits (d=-
1.32) from baseline to 12 
month follow up.  
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teachers.   
 
Wagner et al. 
(2010, 2011) 
COPE 
 
 
9 children aged 
10-15 years and 
9 parents.  
 
Epilepsy 
duration:> 6 
months.  
 
USA.  
One group, 
pre-test/post-
test (maximum 
of 2 weeks 
prior to 
intervention 
and final 
session). 
 
 
CBT based groups 
over 8 weekly 1 
hour sessions or 2 
four hour sessions. 
Child groups 
conducted by 
paediatric 
psychologist and 
parent groups by 
social worker.  
CDI 
SSES-C 
CATIS 
HSC  
SSSS  
ESES 
CHIC 
PIP 
 
T-tests and 
Wilcoxon 
Signed rank 
test. 
* 
Significant improvement in 
children's knowledge of 
epilepsy (g=0.61), self-efficacy 
in seizure management 
(g=0.53) and parent's 
perception of support seeking 
from children (g=0.67) pre- to 
post-intervention.  
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3.4 High Quality Studies 
 
3.4.1 Intervention goals and outcome measures 
Among the three high quality studies, two focussed on reducing anxiety and depression 
[32-34, 36] and the other sought to increase epilepsy knowledge and coping strategies 
[35]. Specifically, Martinovic et al. [36] aimed to prevent depression in 'at risk' 
adolescents with epilepsy while Blocher et al. [32-34] primarily focussed on the reduction 
of anxiety but also examined symptoms of depression and behavioural problems. All 
three studies used standardised outcome measures directly related to their aims and 
used in clinical practice. Jantzen et al. [35] also developed their own measurement scales 
specifically for the study.  
 
3.4.2 Treatment components and methods of delivery 
Only Jantzen et al. [35] included parents in the full intervention, which ran simultaneous 
group psycho-educational programmes for parents and CYPE. The programme was 
researched with CYPE and parents and validated in a pilot using techniques based on 
family and behavioural therapy. It used an interactive story-telling method, tailored to 
age group, with education about epilepsy, emotions and self-management. Parents were 
partially involved in the cognitive behavioural therapy (CBT) intervention used by Blocher 
et al. [32-34]. They met with their child’s therapist for four sessions and at follow up to 
discuss progress, receive a summary of the intervention material covered and contribute 
to developing their child’s exposure hierarchy. Parents were not involved in any aspect of 
the CBT intervention in the Martinovic et al. [36] study. Both CBT interventions were 
delivered individually to the CYPE and incorporated key components of CBT such as: 
relaxation; identifying thoughts, feelings and cognitive errors; and problem solving, with 
exposure tasks tailored to anxiety [32-34] and activity scheduling to depression [36]. 
Additionally, Blocher et al. [32-34] used manualised computer video demonstrations 
delivered by the therapist.   
 
3.4.3 Effectiveness of Interventions 
Effect sizes were moderate-large for improvements in epilepsy knowledge and self-
management skills for the intervention compared to control group in the study by Jantzen 
et al. [35]. Although there were improvements in QoL for CYPE over time, effect sizes 
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were small and only significantly better than the control group on one dimension. There 
was a significant time-by-group effect for parental report of decrease in epilepsy-related 
worries with a moderate effect size. Martinovic et al.'s [36] study had only 15 participants 
in each group but found a significant reduction in depression symptoms on two outcome 
scales and improvement in QoL for the intervention group compared to controls at 9 
month follow up, all with large effect sizes. Blocher et al. [32-34] did not use a control 
group but found a significant reduction in anxiety (large ES), depression (medium ES) and 
problem behaviours (small ES) at 3-month follow up.  
 
3.5 Acceptable Quality Studies 
 
3.5.1 Intervention goals and outcome measures 
Studies of an acceptable quality had the following intervention goals: enhance levels of 
pro-social functioning [40]; improve neurocognitive, emotional and behavioural 
functioning and QoL [41]; increase epilepsy knowledge and improve self-esteem, seizure 
self-efficacy and attitudes towards epilepsy [42]; increase adherence to AEDs [44]; 
increase children's knowledge, perceptions of competency and skills in seizure 
management [25, 26]; improve QoL, management of seizures, and health care utilisation 
of families [45]; improve QoL and psychosocial functioning [46]; enhance coping skills, 
self-efficacy, self-management and promote resilience [27, 28]; improve social skills, 
treatment adherence and reduce social, educational and family difficulties [43]; improve 
knowledge, coping, treatment outcomes and adaptation [29-31]; and increase child 
chronic illness self-management skills (epilepsy and asthma) [47]. Studies used a wide 
range of outcome measures (Table 2 and Appendix 1.4).  The majority used a combination 
of standardised validated psychosocial measures, purpose-designed questionnaires and 
qualitative data. Only one study used an objective measure of medication adherence [44] 
and only one study examined neurocognitive outcomes [41]. Two studies measured 
seizure frequency through parental report [37, 38].  
 
3.5.2 Treatment components and methods of delivery 
Nine of the eleven acceptable quality studies included parents/family directly in the 
interventions.  Six of these ran separate sessions for CYPE and parents/family [25-31, 41, 
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46, 47] whilst in three, families attended all sessions together [43-45]. One had no 
parental involvement [42] and the other provided parents with an intervention manual 
but they were not directly involved [40]. Seven of the studies implemented educational 
interventions [25, 26, 29-31, 42, 44-47], two CBT interventions [27, 28, 40], one family 
counselling [33] and another, an exercise programme [41]. Small sample size did not 
allow for comparison of different delivery methods of CBT (in-person one-day 6 hour 
workshop or 1 hour 6 weekly sessions online) in the Carbone et al. [40] study.  
 
3.5.3 Effectiveness of Interventions 
Of the education-based interventions, Lewis et al. [25, 26] had the largest sample size but 
data was not available to calculate ES. Rather than using a standardised tool to measure 
epilepsy knowledge, they used open ended interview questions in which there was a 
significant improvement on half the items for intervention group compared to controls at 
5-month follow up. Tieffenberg et al. [47] also had a relatively large sample size but again 
it was not possible to calculate ES for all outcomes. Their intervention was not epilepsy 
specific but was for children with chronic illnesses. At 12-month follow up there were 
significant improvements in seizure frequency, emergency hospital visits, and school 
absenteeism but not in parent’s epilepsy knowledge, parental anxiety or number of 
routine medical consultations. Rau et al. [29-31] found ‘social restrictions’ was the only 
area of significant improvement, with a moderate ES, for CYPE in the intervention group 
compared to controls at 3-month follow up. There were no significant differences in 
clinical outcomes (e.g. seizure frequency and medication tolerability) or epilepsy 
knowledge for children but for parents there were significant improvements in the 
intervention group compared to controls in epilepsy knowledge (large ES), seizure 
management, adaptation (moderate ES) and epilepsy related anxiety (small ES). Although 
there was significant improvement in the main outcome of QoL (and also in depressed 
mood) in one study with moderate effect sizes, there was no significant change to CYPE’s 
knowledge about epilepsy as may have been expected from an educational programme 
[39]. Snead et al. [46] had the smallest sample size (7) and perhaps due to this found no 
significant results. Frizzell et al. [42] found large ES for significant improvements in self 
and epilepsy knowledge but there was no improvement on one of the main outcomes, 
self-esteem.  Feedback on the intervention from focus groups was positive. Although 
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Modi et al. [44] found their intervention to be feasible and acceptable to families, 
improvements in medication adherence was only reported in percentages and the study 
did not provide sufficient data for results to be interpreted fully. 
 
Carbone et al. [40] used group CBT and found no significant changes in behaviours from 
baseline to 4-month follow up other than an increase in pro-social behaviour (large ES). 
Better outcomes were reported by parents over time but at baseline their scores were 
lower than adolescents. The authors helpfully considered the characteristics of individuals 
who may benefit most from the intervention e.g. children whose parents had a lower 
level of education and socio-economic status. Wagner et al.’s [27, 28] (2010) CBT 
intervention study found significant improvements across various outcomes but the 
sample size was only 9 and they had eleven outcome measures, increasing the likelihood 
of a type II error.  Glueckauf et al. [43] found their family counselling intervention to be 
effective when delivered via three different means (video-conferencing, speaker phone 
and in person) at 6 month follow up in significantly improving problem severity and 
frequency within families with a large effect size. However, the study had a small sample 
size, reducing  statistical power and improvements in parental measures were not 
maintained at 6-month follow up.  
 
Eom et al.’s [41] exercise intervention found significant improvements in cognitive and 
behavioural domains with small and large effect sizes respectively. However, these results 
should be interpreted with caution due to only having a sample size of 10. Mean 
depression scores were below clinical significance at both pre and post intervention, with 
no significant change in depression or anxiety scores. 
 
3.6 Poor Quality Studies 
 
Poor quality studies will not be discussed in detail due to the weaknesses in their design. 
Austin et al. [37] aimed to improve epilepsy knowledge, attitudes and family functioning 
based on individual family needs through family educational phone sessions. Although 
they produced promising results, the intervention was tailored to individual families, 
meaning it lacked consistency and would be difficult to replicate. Conant et al. [38] aimed 
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to increase social confidence, self-concept and QoL in CYPE and reduce parental anxiety 
through a 10-week group karate programme. However, their only significant finding 
between pre and post intervention was in the memory subscale of parent's perception of 
child's QoL with a moderate effect size. There was no follow up past last session. 
Stafstrom et al. [39] (2012) used art therapy to attempt to enhance self-image in CYPE but 
this was not measured at follow-up. 
 
4. Discussion  
 
4.1 Main Outcomes 
 
In terms of interventions focused on improving mental health, one high quality study [36] 
provides evidence for a significant reduction in depression and improvement in QoL, with 
large effect sizes maintained at 9-month follow up. Another found that at 3-month follow 
up there were significant reductions in anxiety and depression symptoms with moderate-
large effect sizes and in problem behaviours with a small effect size [32-34]. However, the 
second study did not use a control group, reducing confidence that improvements were 
related principally to the intervention. An education-based intervention found 
improvements in QoL and depression scores but not in epilepsy knowledge [45]. 
However, the sample size was small; limiting what can be drawn from these findings. Of 
the two acceptable quality CBT interventions, Carbone et al. [40] reported an 
improvement in pro-social behaviour for adolescents and Wagner et al. [27, 28] found 
improvements in self-efficacy for seizure management knowledge of epilepsy in children. 
Both studies also reported improvements reported by parents, such as an increase in 
child coping skills. However, again, there were no control groups and the sample size for 
one study [27, 28] was particularly small. More positively, a family counselling RCT found 
a significant reduction in problem severity and frequency (in problems in family 
functioning such as child anti-social behaviour) with large effect sizes, maintained at 6-
month follow up. However, parent improvements were not maintained [43].  
 
The literature also provides evidence for the efficacy of psychosocial interventions for 
improving epilepsy knowledge and self-management skills in CYPE and parents [35]. 
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These are target areas recommended in the NICE guideline [16]. As recommended by 
previous research [6] four studies focussed on self-efficacy [25-27, 42, 47]. Improvements 
in epilepsy knowledge were found with large effect sizes in another study but there was 
no control group, moderating the conclusion that the intervention led to changes [42]. 
Improvements in parents' epilepsy knowledge, seizure management and parental 
restrictions with small-moderate effect sizes were found in one study but for CYPE there 
were only minimal improvements in one aspect of QoL at 3-month follow up [29-31]. Of 
the acceptable quality education-based studies, those with the largest participant 
samples and control groups suffered from methodological flaws, such as failure to use 
outcome measures related to mental health or QoL [25, 26, 47], and failure to use a 
treatment comparison group [47]. These prevent definitive conclusions being drawn with 
regard to changes in epilepsy knowledge. The only study to examine cognitive domains 
found significant improvements after an exercise intervention but had no control group 
and a small sample [41]. Similarly, a study focussed on medication adherence had the 
same design flaws in addition to insufficient data analysis [44]. 
 
4.2 Future Research  
 
Whilst the evidence base is limited, there is some evidence for the effectiveness of 
psychosocial interventions for improving mood outcomes for CYPE. When considering 
treatment components, CBT had more reliable evidence for improving these outcomes 
than education-based interventions but it is not possible to make a direct comparison. 
The limited evidence suggests it is not necessary to have direct parent involvement in 
these interventions for improvements in mood to occur. It may be that it is enough to 
have parents involved indirectly through progress meetings and having knowledge of the 
intervention content. Both high quality CBT intervention studies delivered the therapy 
individually, whereas the moderate quality studies ran group interventions. The studies 
with more of a focus on increasing epilepsy knowledge and management were most often 
delivered in groups. The positive outcomes from these studies suggest this is a cost-
effective way to administer education-focussed interventions for CYPE and their families. 
It is unfortunate that some of the studies with a superior design (RCT) or larger samples 
failed to use standardised outcome measures or carry out data analysis beyond 
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descriptive statistics. There is a need for further good quality RCTs with other treatment 
comparison groups. Future research could contain different treatment arms, for example, 
comparing group with individual one-to-one interventions or with parent and child 
groups, in order to evaluate effective treatment components for this population. It may 
also be that different age groups benefit from different interventions, warranting further 
investigation.  
 
Furthermore, only one study included a twelve-month follow up [41]. Ten of the studies 
had a follow up period of one month or more, five with six months or more. Future 
research should utilise longer-term follow up periods to establish if improvements in 
psychosocial functioning are sustained. However, it is also worth considering what extent 
of improvement should be expected in relation to the intensity and level of delivery of 
any psychosocial intervention. In some studies it was unclear who administered the 
interventions but the majority used a wide range of health and social care professionals. 
In one study teachers facilitated the educational groups [47]. It would be helpful to know 
what level of training and qualifications are optimally required to deliver the 
interventions effectively. For example, some interventions may require medical staff and 
clinical psychologists to deliver the interventions while in others training and supervision 
could be provided to other professionals to facilitate the intervention.  
 
As the majority of studies in this review did, it is important for future research to include 
self-report outcome measures completed by both CYPE and their parents/carers. It is 
important that research takes account of the potential bias associated with child versus 
proxy reported outcomes, as often there are discrepancies on psychosocial measures 
[51]. Objective outcome measures such as medication adherence, hospital visits and 
neuropsychological tests were less frequently used in the studies included in this review. 
Using both subjective and objective measures would help increase the validity of findings. 
Given the evidence for cognitive deficits in CYPE [7], it is surprising only one study in this 
review examined cognitive outcomes and further research is clearly required along with 
the use of educational outcome measures such as school performance or teacher report.  
This could help to determine whether psychosocial interventions can impact on academic 
attainment and cognitive skills. The conflicting evidence [7, 13] regarding the influence of 
 
 
33 
 
seizure frequency and severity on psychosocial outcomes, such as mood, social 
functioning and QoL also requires further consideration in well-designed studies.   
 
4.3 Strengths and Limitations 
 
While there have been previous reviews which have looked at psychosocial interventions 
for epilepsy, few have used formal systematic review criteria or they have considered 
adult and child studies together. One systematic review of care delivery and self-
management strategies for CYPE does have a similar scope to the current review [22]. 
However, since half of the studies in the current review were published after their paper, 
it was thought timely to review the literature once more. As the CCAT [1] is an all-
encompassing tool, unlike the review mentioned above, the current systematic review 
was not limited to only true experimental studies. Incorporating data from across 
research designs into a single review provides a wider range of intervention options and 
ideas for readers to draw upon. This could aid the selection of treatment components, 
methods of delivery and outcome measurements based on the resources available to 
services. The inclusion of a wider range of study designs was appropriate in this area since 
it is often not possible for psychosocial studies to include randomised control groups and 
long-term follow up periods due to funding and ethical restrictions. The CCAT also 
allowed for the incorporation of evaluation of papers based on their reporting, in the 
overall assessment of studies. 
 
The age range of CYPE in these studies ranged from 7 to 19 years and the minimum 
epilepsy duration ranged from 2 to 12 months. It may be useful for future reviews to 
focus on the influence of these factors, specifically as early intervention is promoted for 
psychosocial wellbeing. It should be noted that studies which included participants with a 
learning disability were excluded from the current review. Given that epilepsy is common 
in the learning disability population, the generalisability of the current findings are 
restricted and this area requires greater attention. Furthermore, the review did not 
consider intervention effects on different types of epilepsy and other factors such as 
epilepsy duration. This was primarily due to varying levels of reporting of these factors in 
previous studies. Nevertheless, this is an area that merits examination. The current 
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review did not carry out a meta-analysis of the studies due to the heterogeneity of 
methodologies and outcome measures used. The current review therefore lacks the 
benefits that a meta-analysis provides, such as overcoming small sample sizes of 
individual studies and increased precision in estimating effects.  
 
4.4 Conclusions 
 
In conclusion, there were some promising findings produced from the studies in this 
review with regard to the effectiveness of psychosocial interventions in increasing 
epilepsy knowledge and self-management, and in improving QoL and psychological 
symptoms such as anxiety and low mood. The evidence indicates that both CBT based and 
educational interventions are effective to an extent but findings were not unanimous 
across all studies. The differences in the quality of these studies could explain these 
inconsistencies. No single treatment components can be identified as superior at present. 
Further research with larger samples, control groups and objective outcome measures is 
required.  
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Plain English Summary 
 
Background 
 
Problems with sleep and memory are common in children with epilepsy. Previous studies 
have shown that many people with epilepsy forget information they have learned at a 
faster rate than people without epilepsy.  This is a recent finding and therefore little is 
known about the factors that influence rate of forgetting. As there is a well-established 
relationship between sleep and memory abilities, the present study aimed to investigate 
if there is an association between rate of forgetting and sleep in children with epilepsy. It 
also investigated the relationship between learning efficiency (i.e. how often information 
is presented before it is learnt) and sleep.  
 
Questions addressed by this study 
 
1. Is poorer sleep quality and duration associated with a higher rate of forgetting 
over time in children with epilepsy? 
2. Is poorer sleep quality and duration associated with poorer ‘learning efficiency’? 
 
How this was done 
 
Nineteen children with epilepsy were asked to memorise stories and a list of words from 
a standardised neuropsychological memory test. They were then asked to repeat the 
stories and word list 30 minutes after learning them and then again, one week later. Their 
recognition for the information was also tested at these time points. During this week-
long period their sleep duration and quality was measured through use of an actiwatch (a 
small watch-like device recording rest and activity patterns) and children and their 
parents completed a sleep diary. Parents also completed two questionnaires about their 
children's sleep and memory over the week-long period. Children completed a 
questionnaire about their sleep. 
 
Results and Conclusions 
 
The data showed no relationship between sleep duration or sleep efficiency and rate of 
forgetting. The results provided some evidence that children who took longer to get to 
sleep had a higher rate of forgetting for recalling and recognising previously learned 
information. Results relating to sleep and learning efficiency were mixed, therefore little 
can be concluded about the relationship between them. These mixed results are due to 
the small sample size. Further research is required to learn more about the exact nature 
of the relationship between sleep and rate of forgetting in children with epilepsy.  
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Abstract 
 
Objective 
Given the well-established association between epilepsy and sleep disturbance and the 
evidence suggesting the importance of sleep in memory consolidation, there is reason to 
investigate the relationship between sleep and rate of forgetting in children with 
epilepsy. This study aimed to investigate the relationship between sleep and forgetting in 
children with Genetic Generalised Epilepsy (GGE).  
 
Methods 
Participants were 19 children with GGE (9-15 years old). Actigraphy, sleep diaries and 
standardised questionnaires were used to measure sleep over a week long period. Rate of 
forgetting was measured using neuropsychological tests at the beginning and end of the 
study week. Spearman’s correlation analysis was used to determine if poorer sleep was 
associated with poorer initial learning and rate of forgetting in verbal memory recall and 
recognition.  
 
Results 
No association was found between sleep efficiency or duration and rate of forgetting. 
Measures of sleep disturbance were mixed, with sleep onset latency found to be 
associated with rate of forgetting on the Word Lists test. However, increased wake after 
sleep onset was associated with decreased rate of forgetting.  
 
Conclusions 
Whilst there was limited evidence of a relationship between some actigraphic sleep 
parameters and rate of forgetting for verbal information, the results were mixed and 
likely biased by the small sample size. There is need for further research with a larger 
sample to establish the nature of the relationship between sleep and rate of forgetting in 
children with GGE.  
 
Keywords: Sleep; Forgetting; Memory Consolidation; Children; Epilepsy 
Word Count: 7,797
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1. Introduction 
 
The phenomenon of accelerated long-term forgetting (ALF), in which newly acquired 
memories are intact after short delays but fade over days to weeks, has become an 
increasingly prominent area of epilepsy and cognition research. ALF has recently been 
established to occur more often in both adult and paediatric epilepsy populations 
compared to healthy controls [1, 2]. However, little is currently known about the factors 
that influence ALF. Given the well-established association between epilepsy and sleep 
disturbance [3-5] and the evidence suggesting the importance of sleep in memory 
consolidation [6, 7] there is reason to investigate the relationship between ALF and sleep 
in children with epilepsy (CWE). 
 
First identified in adults with temporal lobe epilepsy (TLE) [8], the mechanisms that 
underlie ALF are debated with most attention given to theories of consolidation. Research 
into ALF suggests that the temporal gradient required for new information to be 
successfully consolidated into long-term memory is extended beyond minutes and the 
process could potentially take days, weeks or longer [8]. The exact time course and 
mechanisms of memory consolidation remain unclear. It is speculated that the process of 
consolidation involves an interaction between the hippocampus and neocortex [9, 10], 
areas that often suffer neuronal damage from seizure disorders [10]. However, recent 
neuroimaging studies found no relationship between structural anatomical damage and 
ALF [11, 12]. This may suggest that ALF is a consequence of subclinical epileptiform 
activity disrupting interactions between the mesial temporal lobe (MTL) and the 
neocortex. Indeed, in a review of ALF case reports and group studies, it was concluded 
that ALF posed a challenge to current theoretical models of memory [1].  
 
Three studies to date have demonstrated ALF in paediatric epilepsy populations. Two 
found that children with idiopathic generalised epilepsy (IGE) demonstrated ALF for 
verbal information compared to matched controls after a one-week delay, but no effect 
for non-verbal information [13, 14]. Davidson et al. [13] found that CWE required a 
greater number of learning trials to reach a learning criterion compared with controls, 
whereas Shepley et al. [14] found no difference. In both studies ALF was demonstrated 
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for verbal recall but not for recognition, suggesting that difficulties in retrieving 
successfully stored information characterised ALF. However, Gascoigne et al.’s [15] study 
was consistent with the consolidation hypothesis. Similarly, they found children with IGE 
recalled fewer words than controls after a week, but not a thirty-minute delay. They 
found no significant difference between the epilepsy group and controls in the number of 
initial learning trials and also found deficits in recognition over a delay in the IGE group. 
Although there is debate between the studies regarding the mechanisms underlying ALF, 
they all evidence that CWE experience deficits in new learning.  
 
Sleep dependent memory consolidation is the process whereby memory traces are 
preferentially consolidated during sleep as opposed to wakefulness, leading to an 
improved performance after a retention interval including a sleep phase [6]. Non-rapid 
eye movement (NREM) has been shown to have a role in the consolidation of both verbal 
and nonverbal declarative memories in healthy children, as demonstrated by 
improvement in performance after sleep compared to a period of wakefulness [16]. 
Diekelmann et al. [17] also provide a review of studies in the area of sleep-dependent 
memory consolidation. Children with high amounts of slow-wave-sleep (SWS) post-
learning had distinctly enhanced declarative memories. Ashworth et al. [18] used 
actigraphy and novel learning tasks to investigate sleep-dependent memory consolidation 
in typically-developing children. No change in recall performance was found after a wake 
period but recall scores improved significantly following a period of sleep, regardless of 
whether initial training took place in the morning or evening. Of note, the average wake 
period (10hrs 25mins) was shorter than the average sleep period (13hrs 14mins). In adult 
epilepsy populations, evidence for the role of sleep on memory function is mixed [19-21]. 
A recent review of the relationship between sleep and the effect on cognitive functioning 
in CWE highlighted the influence of sleep disruption on the neurophysiological and 
neurochemical mechanisms important for the memory–learning process [22]. It was 
concluded that improvement in the long-term cognitive–behavioural prognosis of CWE 
requires good sleep quality as well as good seizure control.  
 
Two recent studies have examined the relationship between memory consolidation and 
sleep in CWE. Sud et al. [23] aimed to determine whether CWE were better able to 
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consolidate memories after a sleep versus a wake period. Participants were presented 
with word lists over five learning trials and recall was tested immediately and again after 
a delay. Each participant was tested twice, after a period of wakefulness and after a 
period of sleep, with conditions counterbalanced among participants. The length of the 
wake and sleep delay intervals were matched for each child. It was found that recall was 
significantly better after sleep compared to a period of wakefulness in 7/10 participants 
but this sleep-memory relationship was not demonstrated in the group analysis. Due to 
the small sample and good sleep efficiency of the group, consideration of how poor sleep 
may impact on consolidation was restricted.  Gaeler et al. [24] found overnight recall 
performance on declarative memory tasks to be lower in CWE than in control children, 
further confirming ALF in CWE. Higher spike–wave index (SWI) during NREM sleep (as 
measured by polysomnography (PSG) and electroencephalography (EEG)) was associated 
with poorer performance in the nonverbal task but not the verbal task. They concluded 
that interictalepileptiform discharges (IED) could disrupt sleep memory consolidation. 
 
Although the above studies have investigated whether sleep improves memory 
consolidation in CWE, they compared sleep and wake periods with recall over periods no 
longer than twenty-four hours. The current study extends this investigation by analysing 
the relationship between sleep parameters and rate of forgetting over a week long period 
in children with GGE. Determining whether there is a relationship between sleep 
parameters and rate of forgetting could inform how learning could be improved in CWE, 
and may also identify those children most at risk of education attainment problems. In 
turn, this could encourage and inform future research in designing effective psychological 
and educational interventions. 
 
1.1 Aim 
To investigate the relationship between behavioural sleep disturbance and rate of 
forgetting in children with GGE.  
 
1.2 Hypotheses 
1) There will be a positive correlation between children's ‘sleep efficiency’ (and 'total 
sleep time') and their percentage recall between thirty minutes and one week.  
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2) There will be a negative correlation between sleep disruption ('sleep onset latency' and 
'wake after sleep onset') and percentage recall between thirty minutes and one week.  
 
3) There will be a negative correlation between the ‘number of learning trials it takes to 
learn the minimum criterion’ for the verbal memory tests and ‘sleep efficiency’/ ‘total 
sleep time’. 
 
4) There will be a positive correlation between ‘number of learning trials to minimum 
learning criterion’ for the verbal memory tests and sleep disruption ('sleep onset latency' 
and 'wake after sleep onset').  
 
2. Methods 
 
A cross-sectional correlational research design was used to explore the relationship 
between ALF and sleep parameters.  
 
2.1 Ethical Approval 
 
Ethical approval was granted by the North of Scotland Research Ethics Committee 
(Appendices 2.1 & 2.2). Site approval was awarded by NHS Greater Glasgow and Clyde 
Research and Development Department and NHS Lothian Research and Development 
Department (Appendices 2.3 & 2.4).  
 
2.2 Justification of Sample Size 
 
As there were no correlational studies looking at sleep and ALF in children with epilepsy, 
studies with related constructs in adults were used to derive an estimate of the sample 
size required for adequate statistical power. Deak et al. [19] found a moderately strong 
correlation between delayed recall on a selective reminding word list test and slow wave 
sleep (r = 0.64) in adults with temporal lobe epilepsy. Similarly, Clemens et al. [25] found 
moderately strong positive correlations between delayed recall on a verbal memory test 
and sleep stage 2 spindle activity measured by EEG (r = 0.73, r = 0.66, r = .54, r = 0.52). 
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Schabus et al. [26] also found a moderately strong positive correlation between sleep 
stage 2 spindle activity and delayed recall for a word-pair test in young adults (r = 0.63). 
On this basis, a large effect size (r = 0.50) was assumed for the current study, with the 
power set at .80 and alpha at .05 [27]. A power calculation using G*Power [28] provided a 
sample size estimate of 29 for the main hypothesis.   
 
2.3 Participants  
 
Recruitment took place between January and June 2015 at the Royal Hospital for Sick 
Children (RHSC) Glasgow and RHSC Edinburgh. Inclusion criteria included children aged 
between 9 and 16 years with a diagnosis of GGE, according to ILEA criteria [29] and 
fluency in English. Exclusion criteria included: 1) learning disability (i.e. IQ of less than 70); 
2) presence of another major health or physical condition; 3) history of a neurological 
disorder other than epilepsy; 4) history of head injury; 5) history of a specific sleep 
disorder; and 6) history of major psychiatric disorder. Twenty-eight children receiving 
care at the epilepsy clinics and identified as meeting criteria were invited to participate by 
their consultant neurologist or specialist nurse. Potential participants and their parents 
were provided with written information about the study (Appendices 2.5-2.9) and then 
either contacted the researcher directly or provided written consent to their clinician for 
the researcher to contact them. Nineteen families (68% of potential participants 
contacted) consented to participate and were included in final analysis. Written informed 
consent was obtained from all children and their parent prior to participation 
(Appendices 2.10-2.12).  
 
2.4 Procedure 
 
Participants attended two appointments, one week apart, at either RHSC Glasgow or 
RHSC Edinburgh. During the first appointment children completed neuropsychological 
tests and a questionnaire with the researcher, while parents completed a proxy 
questionnaire independently. The tests were administered in quiet clinic rooms and 
breaks were provided during testing where required. Participants and parents were 
provided with guidance on the use of the actiwatch and on the completion of sleep and 
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seizure diaries, all of which were taken home for one week. Information on 
epilepsy/seizure variables, medication, memory and sleep was also collected from 
participants/parents. At the second appointment, neuropsychological tests were re-
administered with children, parents completed a second questionnaire and data from the 
actiwatch, sleep and seizure diaries was collected. The first appointment typically lasted 
one hour and the second fifteen minutes.  
 
2.5 Measures 
 
2.5.1 Demographic Information 
Socio-economic status (SES) was rated using the Scottish Index of Multiple Deprivation 
(SIMD) [30] on the basis of postcode. The SIMD estimates deprivation in small 
geographical areas across Scotland with scores ranked from most to least deprived and 
then split into 10 deprivation deciles.  
 
2.5.2 The Wechsler Abbreviated Scale of Intelligence (WASI) [31] 
The two subtest form of the WASI was administered to ensure participants met the 
minimum IQ inclusion criterion. The vocabulary and matrix reasoning subtests provide a 
brief, reliable measure of cognitive ability, suitable for use in clinical and research 
settings.  
 
2.5.3 The Children’s Memory Scale (CMS) [32] 
The Stories and Word Lists subtests were used to assess participants’ verbal memory. The 
Stories test involved reading two short stories to the participant, who was then asked to 
repeat them verbatim. Participants were required to learn each story to a level of 90% 
accuracy (learning criterion). During the Word List test, participants were read a list of 14 
unrelated words and then immediately asked to recall as many words as possible. 
Participants were then selectively reminded of words they omitted on the previous trial 
and again asked to recall the entire list. Selective reminding of missed items was provided 
until participants reached 85% accuracy, allowing for 2 words to be missed from the recall 
list. Both tests had a maximum of ten consecutive learning trials. Following the last 
learning trial, participants' recall and recognition of the material was tested after a 30-
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minute delay and then again after a 1-week delay. Children were asked to recall the 
stories as best they could and as many of the words from the list as possible. Recognition 
for Stories was tested using thirty true or false questions and for Word Lists through the 
identification of the original 14 words from a list of 42 words read to them containing 
target and distractor words. Children were instructed not to rehearse or write down the 
material during the 1-week delay.  
 
2.5.4 The Observer Memory Questionnaire - Parent Form (OMQ-PF) [33] 
This 27-item questionnaire provided a subjective parental-report of their child's everyday 
memory abilities, with a higher score being optimal. The OMQ-PF was significantly 
correlated with immediate and delayed recall on standardised neuropsychological tests in 
a sample of CWE.  
 
2.5.6 Actigraphy using Actiwatch 2 (Philips Respironics) 
Actigraphy was used as an objective measure of sleep between the two recall/recognition 
time points (30-minutes and 1-week). The Actiwatch is a nonintrusive watch-like device, 
which provides information on sleep/wake cycles in the participants' natural sleep 
environment. It records and monitors movement for one-minute epochs through a 
wristwatch microprocessor link and provides estimates of sleep and nap times based on 
periods of wrist immobility. Acebo et al. [34] recommend that studies aiming to gather 
five nights of actigraph data for children and adolescents should record for at least one 
full week to ensure a reliable measurement is obtained. The actiwatch was worn on the 
non-dominant wrist continuously for seven nights.  Data was downloaded to a computer 
for calculation of sleep outcomes using Philips Respironics Actiware Software version 
6.0.2, set to a medium default setting. From this, the following objective measures were 
obtained according to the manufacturer’s predefined algorithms:  Time in Bed (TIB); Total 
Sleep Time (TST - total night-time sleep); Sleep Onset Latency (SOL - time required for 
sleep initiation following ‘‘lights out’’); Wake After Sleep Onset (WASO - total time spent 
awake after first sleep initiation); Sleep Efficiency (SE - percentage of time spent in bed 
asleep). Actigraphy data were then checked against sleep diary estimates for each 
participant, as recommended by Acebo et al. [34], and adjusted accordingly.  
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2.5.7 Sleep Diaries 
Children and their parents were asked to complete sleep diaries recording bed, "lights-
out", wakening and rise times, daytime naps and watch removal (e.g. for swimming) over 
the seven nights of participation, in parallel with actigraphy monitoring. Sleep diaries not 
only provide a subjective report of sleep but can help provide corroboration of actigraphy 
data and assist with the interpretation of ambiguous actigraphy data, for example by 
discriminating between naps and periods of inactivity. 
 
2.5.8 The Children's Sleep Habits Questionnaire (CSHQ) [35] 
The CSHQ provided a subjective parental-report of their child's sleep over the 
participation week. Frequency ratings for 33 items of the most common sleep problems 
are scored on a 3-point scale and the parent can indicate whether or not a behaviour is 
problematic. A higher score is indicative of more disturbed sleep and a cut-off score of 41 
indicates sleep disturbances with a sensitivity of 0.80 and specificity of 0.72 [35]. 
 
2.5.9 Sleep Self Report (SSR) [36] 
This 26-item questionnaire provided a subjective child-report of frequency of sleep 
behaviours, rated on a 3-point scale. The SSR was designed to assess sleep domains 
similar to those of the CSHQ, with a higher score indicating more sleep problems. The SSR 
was completed independently or with the assistance of the researcher depending on age 
and ability of child.  
 
2.5.10 Seizure Diaries 
Parents recorded seizure frequency over the participation week along with information 
on average seizure frequency, epilepsy onset, status and medication.  
 
2.6 Data Analysis 
 
SPSS statistics (version 19) was used to analyse the data. Participant characteristics were 
explored using descriptive statistics. To determine the rate of forgetting over time, the 
percentage recalled and recognised between 30-minutes and 1-week was calculated for 
each participant using the following calculation: (1-week score/30-minute score) x100. A 
 
 
51 
 
lower percentage recalled from 30-minutes to 1-week indicates a higher rate of 
forgetting. Bland-Altman analysis was used to assess the level of agreement between 
actigraphy and sleep diary measures.  A range of agreement was defined as mean bias 
±1.96 SD. A Bland-Altman analysis has been accepted as the standard statistical approach 
to assess the agreement between two methods of clinical measurement [37, 38]. After 
examining distributions of data for normality, associations between measures of 
forgetting, sleep, IQ and age were examined using Spearman’s rho. Wilcoxon signed ranks 
tests and linear regressions were undertaken as secondary exploratory analysis to further 
investigate relationships between variables. 
 
3. Results 
 
3.1 Demographic Variables 
 
Data from 19 participants (14 females, 5 males) were collected and analysed. The study 
did not reach the desired sample size of 29 to achieve a statistical power of 0.80. 
Participants ranged in age from 9 to 15.5 years (Mdn = 11.3, IQR = 10.3, 13.0). Socio-
economic status decile rank ranged from 1 to 9 (Mdn = 5, IQR = 2, 6) [30]. Almost half of 
the sample (47%) lived within the category of the 30% most deprived areas in Scotland. 
As the group was heterogeneous, clinical characteristics for individual participants are 
provided in Table 1. WASI full scale IQ ranged from 75 to 118 (Mdn = 88, IQR = 85, 100). 
17/19 (90%) participants were treated with antiepileptic drugs and 79% had an epilepsy 
duration of 12 months or more. Seizure types experienced by the group included: 
absence only (47%); tonic clonic (16%) and mixed in 37%. 3/19 participants (15%) were 
seizure free for two years or more (remitted epilepsy). During the study week, 9/19 
participants (47%) had one or more seizures.  
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Table 1 
Clinical Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*JME (Juvenile myoclonic epilepsy); JAE (Juvenile absence epilepsy); FS-Plus (Febrile seizure plus); EM (Eyelid myoclonia with absences); CAE (Childhood absence 
epilepsy); FAE (Familial Absence Epilepsy); U-GGE (Unspecified Genetic Generalised Epilepsy) AE (Absence epilepsy); A (Absence Seizure), B (Tonic Clonic Seizure) 
Gender 
Age 
(Years. 
Months) 
Full 
Scale 
IQ 
Epilepsy 
Duration 
(Months) 
Epilepsy 
Syndrome* 
Seizure 
Type* 
No. seizures 
during study 
week 
Average Seizure 
Frequency AED 
F 15.5 101 96 JME A,B 0 Monthly Lamotrigine/ Topiramate  
F 11.9 86 19 JAE A,B 4A, 1B Weekly Sodium valporate/ Zonisamide  
M 9.8 77 60 FS-Plus A 3A Weekly Sodium Valproate 
F 10.9 83 7 EM B > 40A Daily Ethosuximide 
F 10.8 88 6 JME A,B 1B Monthly Levetiracetam 
M 12.1 88 111 AE A,B 0 Seizure free ≥ 2 years Lamotrigine 
M 11.2 118 8 CAE A 0 Weekly None  
F 9.0 113 30 CAE A 4A Weekly Ethosuximide 
F 9.4 111 22 FAE A 1A Weekly Lamotrigine/ Ethosuximide  
F 11.2 79 86 CAE A 0 Seizure free ≥ 2 years Ethosuximide 
F 12.9 94 13 JAE A 1A 1 or 2 annually  Sodium Valporate 
F 9.8 86 28 JAE A 0 1 or 2 annually  Sodium Valporate 
M 14.6 88 77 U-GGE A, B 0 Seizure free = 1 year Sodium Valporate 
M 9.6 89 14 CAE A, B 0 Weekly Sodium Valporate  
F 13.4 99 22 JME B 0 1 or 2 annually  Levetiracetam 
F 11.3 103 96 CAE A 0 Seizure free = 1 year Ethosuximide 
F 14.5 75 6 JME B 1B Monthly Levetiracetam 
F 13.11 86 94 AE A 0 Seizure free ≥ 2 years None 
F 12.1 83 54 U-GGE A >7A Daily Sodium Valporate 
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3.2 Recall, Recognition and Rate of Forgetting 
 
Distributions of the frequency of sleep and memory measures were examined using 
boxplots, and were not normally distributed.  Therefore, these variables are described 
using the median along with interquartile range (Table 2). Spearman’s rho correlations 
(rs) were used to analyse the associations between the number of learning trials to 
criterion for the Stories and Word List tests and the recall and recognition scores (Table 
3). There was a significant negative correlation between the Stories number of learning 
trials to criterion and 30-minute recall (rs =  - 0.63, p <0.01), with a large effect size but an 
association was not evident in any of the other recall or recognition outcomes. For Word 
Lists number of learning trials to criterion, there was a significant negative correlation 
with 30-minute recall (rs = -0.58, p <0.01), with a large effect size. These relationships 
indicated an association between an increase in learning trials and decrease in recall at 30 
minutes on Stories and Word Lists. For Word Lists only, there was evidence of a 
significant positive relationship between learning trials and % recalled from 30-Minutes to 
1-Week (rs = 0.51, p <0.05), with a large effect size. A Wilcoxon signed ranks test was 
carried out to compare the median recall rates of forgetting on the Stories and Word Lists 
test. Of the 19 participants, 13 performed better on the Stories test compared to the 
Word Lists test while 1 participant showed no difference and 5 performed worse on the 
Stories compared to Word Lists. A Wilcoxon signed-rank test determined that Stories % 
recalled from 30-minutes to 1-week (Mdn = 79.09, IQR = 70.43, 92.27) was statistically 
significantly higher than Word Lists % Recalled from 30-minutes to 1-week (Mdn = 60, IQR 
= 47.73, 80.36), z = -1.982, p = 0.048. 
 
Scores for parents of the current sample on the OMQ (M = 85, SD = 21.82) ranged from 
56 to 126, and OMQ did not correlate with any of the CMS outcomes. In a 2008 study 
[33], a sample of healthy children (n = 376, M = 107.26, SD = 13) and a sample of children 
with TLE (n = 44, M = 93.48, SD = 23.04) were compared. The mean OMQ seen in the 
current sample is lower than both of these groups. 
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Table 2 
Children’s Memory Scale and Observer Memory Questionnaire Descriptive Statistics 
 
* % recall for Stories, raw score out of 14 for Word Lists; **out of 30 for stories, out of 42 for Word Lists
  Stories Word Lists 
Children's Memory Scale Median (IQR) Mean (SD) Range Median (IQR) Mean (SD) Range 
Number of Learning Trials to Criterion 7.00 (6.00, 8.00) 8.26 (4.19) 4.00 - 20.00 6.00 (5.00, 10.00) 7.05 (2.46) 4.00 - 10.00 
Last Learning Trial * 91.46 (90.79, 95.12) 92.9 (2.69) 90.24 - 98.94 12.00 (12.00, 12.00) 12.26 (0.56) 12.00 - 14.00 
30-Minute Recall * 76.83 (73.17, 86.29) 76.73 (12.00) 47.90 - 92.68 8.00 (7.00, 10.00) 8.26 (2.35) 2.00 - 12.00 
1-Week Recall * 60.97 (55.22, 71.34) 58.89 (21.37) 0.00 - 86.00 6.00 (4.00, 6.00) 4.79 (2.59) 0.00 - 10.00 
% Recalled from 30-Minutes to 1-Week 79.09 (70.43, 92.27) 76.10 (27.94) 0.00 - 114.94 60.00 (47.73, 80.36) 64.06 (45.15) 0.00 - 200.00 
30-Minute Recognition Score ** 28.00 (27.00, 28.50) 27.53 (1.84) 23.00 - 30.00 41.00 (40.00, 42.00) 41.00 (1.20) 38.00 - 42.00 
1-Week Recognition Score ** 27.00 (26.00, 27.10) 26.79 (1.32) 24.00 - 29.00 36.00 (34.00, 37.50) 35.89 (3.74) 27.00 - 42.00 
% Recognition from 30-Minutes to 1-Week 96.55 (94.81, 101.85) 97.67 (7.04) 85.71 - 113.04 87.5 (83.13, 91.49) 87.45 (7.80) 71.05 - 100.00 
       
Observer Memory Questionnaire 78.00 (73.00, 100.00) 85.00 (21.82) 49.00 - 126.00       
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Table 3 
CMS Spearman’s Correlations for Number of Learning Trials 
  
Stories No. 
of Learning 
Trials to 
Criterion   
Word Lists 
No. of 
Learning 
Trials to 
Criterion 
    
Stories 30-Minute Recall  rs = -0.63** WL 30-Minute Recall  rs = -0.58** 
Stories 1-Week Recall  rs = -0.34 WL 1-Week Recall  rs = 0.15 
Stories % Recalled from      
30-Minutes to 1-Week 
rs = -0.03 Word Lists % Recalled from 
30-Minutes to 1-Week 
rs = 0.51* 
Stories 30-Minute 
Recognition 
rs = -0.30 
WL 30-Minute Recognition 
rs = 0.21 
Stories 1-Week Recognition rs = -0.04 WL 1-Week Recognition rs = -0.02 
Stories % Recognition from 
30-Minutes to 1-Week 
rs = 0.28 Word Lists % Recognition 
from 30-Minutes to 1-Week 
rs = -0.07 
* p <0.05; **p <0.01 
 
3.4 Sleep 
 
Descriptive statistics for actigraphy, sleep diary and sleep questionnaire measures are 
displayed in Table 4. The actigraphy outcomes (Time in Bed, Total Sleep Time, Sleep Onset 
Latency, Wake After Sleep Onset and Sleep Efficiency) were calculated from 7 nights of 
data from all but two participants, where 6 nights was used. This was due to actiwatch 
battery drainage in one case and extreme disagreement between the sleep diary and 
actigraph in the other. Agreement between participants' self-report sleep diaries and the 
objective actigraphy measure of sleep was explored using Bland-Altman analysis. 
Although participants reported their TIB and TST to be longer and their SE to be higher 
than was objectively measured by actigraphy, the Bland-Altman plots of sleep diary and 
actigraphy did not show evidence of any systematic differences, indicating an acceptable 
level of agreement for these two measures. Twelve parents (63%) scored their children 
above the cut-off score of 41 on the CSHQ, indicating they have sleep disturbance. 
Thirteen parents (68%) indicated that sleep behaviours were problematic. On the SSR, a 
higher score (where the maximum possible is 69) indicates disturbed sleep or more 
problematic sleep behaviour, with scores in the current sample ranging from 24 to 58. Six 
children (32%) indicated that they have trouble sleeping. The current sample had a higher 
mean score (n = 19, M = 37.58, SD = 7.22) compared to a healthy cohort (n = 24, M = 
18.62, SD = 3.28) observed in a study looking at SSR in healthy children and children with 
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ADHD [36]. Spearman rho correlations were used to explore the association between self 
and parent reported sleep quality (SSR and CSHQ) and actigraphy outcomes (Table 5). The 
correlations between sleep efficiency as measured by actigraphy and the SSR and CSHQ 
indicate the presence of a relationship, which may be more evident given a larger sample. 
 
Table 4 
Actigraphy Descriptive Statistics 
  Median (IQR) Mean (SD) Range 
Actigraphy Sleep Analysis    
Time in Bed (hr:min) 09:38 (09:02, 10:02) 09:27 (01:05) 06:54 - 11:13 
Total Sleep Time (hr:min) 07:59 (07:21, 08:22 ) 07:53 (00:48) 06:09 - 09:05 
Sleep Onset Latency (hr:min) 00:12 (00:09, 00:19) 00:20 (00:22) 00:04 - 01:21 
Wake After Sleep Onset (hr:min) 00:48 (00:37, 00:57) 00:50 (00:18) 00:22 - 01:26 
Sleep Efficiency (%) 85.31 (81.39, 87.29) 84.52 (4.37) 75.18 - 92.26 
    
Sleep Diary - Subjective Report    
Time in Bed (hr:min) 10:22 (09:44, 10:52) 10:20 (00:52) 09.01 - 11.47 
Total Sleep Time (hr:min) 09:12 (08:30, 09:50) 09:20 (00:52) 08.16 - 11.11 
Sleep Efficiency (%) 91.41 (88.94, 93.17) 90.37 (4.13) 80.54 - 95.79 
    
Sleep Self Report (Total Score) 36.00 (34.00, 41.50) 37.58 (7.22) 24.00 - 58.00 
Children's Sleep Habits 
Questionnaire (Total Score) 
45.00 (39.50, 48.50) 45.47 (10.30) 33.00 - 73.00 
 
3.5 Associations between Rate of forgetting and Sleep  
 
Relationships between rate of forgetting, number of learning trials and actigraphy 
outcomes (SE, TST, SOL, WASO) were explored using Spearman’s rho correlations and are 
displayed in Table 5. There was no evidence of significant relationships between SE or TST 
and any of the CMS variables. A significant negative relationship was found between SOL 
and Word Lists % Recalled from 30-Minutes to 1-Week (rs = -0.47, p <0.05). A significant 
negative relationship was found between SOL and Word Lists % Recognition from 30-
Minutes to 1-Week (rs = -0.66, p <0.01); an increase in SOL was significantly correlated 
with a decrease in WL % Recalled and Recognised from 30-Minutes to 1-Week. There was 
a mild positive relationship between WASO and Word Lists number of learning trials to 
criterion (rs = 0.44, p <0.05); indicating that an increase in WASO was associated with an 
increase in learning trials.  
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One correlation revealed an unexpected finding. There was a significant positive 
correlation between WASO and Word Lists % Recalled from 30-Minutes to 1-Week (rs = 
0.48, p <0.05). This indicated that an increase in WASO was associated with an increase in 
Word Lists % Recalled from 30-Minutes to 1-Week.  
 
Table 5 
Rate of Forgetting and Sleep Spearman’s Correlations 
n=19  
Sleep 
Efficiency 
Total 
Sleep 
Time 
Sleep 
Onset 
Latency 
Wake 
After 
Sleep 
Onset 
Sleep Self Report rs = 0.36 rs = 0.12 rs = -0.24 rs = 0.09 
Children's Sleep Habits 
Questionnaire 
rs= 0.28 rs = -0.13 rs = -0.21 rs = -0.21 
     
No. of learning trials to criterion rs = 0.01 rs = 0.16 rs = 0.01 rs = -0.11 
Stories % Recalled from       
30-Minutes to 1-Week 
rs = -0.16 rs = 0.10  rs = -0.31  rs = 0.45 
Stories % Recognition from  
30-Minutes to 1-Week 
rs = 0.10 rs = 0.24 rs = -0.17 rs = 0.17 
     
No. of learning trials to criterion rs = 0.04 rs = 0.23 rs = -0.44 rs = 0.44* 
Word Lists % Recalled from  
30-Minutes to 1-Week 
rs = 0.09 rs = 0.35  rs = -0.47* rs = 0.48* 
Word Lists % Recognition from  
30-Minutes to 1-Week 
rs = 0.25  rs = -0.01 rs = -0.66** rs = 0.23 
*p <0.05; **p <0.01 
 
3.6 Regression Analysis 
 
Based on the correlation results between CMS and actigraphy outcomes, variables with 
the strongest relationships were explored further with linear regression analysis. Residual 
plots were used to verify the assumptions of linear regression, and revealed no problems. 
Regression analysis was carried out using the rate of forgetting on Word Lists % scores 
from 30-Minutes to 1-Week as response variables and SOL as a predictor variable, while 
adjusting for baseline, IQ, age and number of learning trials in separate models (see Table 
6). SOL, adjusted for baseline (30-minute recall score) and age, significantly predicted 
Word Lists % Recalled from 30-minutes to 1-week, F(3, 15) = 8.488, p < 0.001. Adjusted R2 
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= 0.555 shows that SOL, adjusted for baseline and age together, explain 55.5% of the total 
variability in Word Lists % Recall from 30-minutes to 1-week. In the current sample, as 
SOL increased by 1 minute, Word Lists % Recalled from 30-minutes to 1-week significantly 
(p = 0.004) decreased by 1.49% on average, after adjusting for baseline and age. In the 
wider population of similar patients, this decrease is likely to be between 0.57 and 2.42% 
(95% C.I). While this was the strongest relationship, SOL adjusted for the following 
variables: baseline; baseline and IQ together; and baseline and number of learning trials 
together, was also associated with both Word Lists % Recalled and Recognised from 30-
minutes to 1-week.  
 
Table 6 
Regression Analysis 
Response Variable Predictor Variable B 95% CI P-value 
     
Word Lists % Recalled from 
30-Minutes to 1-Week 
SOL, adjusted for baseline -1.26 (-1.96, -0.57) 0.001 
SOL, multivariable* -1.20 (-1.94, -0.45) 0.004 
SOL, multivariable** -1.47 (-2.29, -0.66) 0.002 
SOL, multivariable*** -1.49 (-2.42, -0.57) 0.004 
     
Word Lists % Recognition 
from 30-Minutes to 1-Week 
SOL, adjusted for baseline -0.22 (-0.36, -0.08) 0.004 
SOL, multivariable* -0.20 (-0.35, -0.05) 0.011 
SOL, multivariable** -0.26 (-0.38, -0.14) <0.001 
SOL, multivariable*** -0.29 (-0.45, -0.12) 0.002 
B = unstandardised regression coefficient; *Multivariable model is adjusted for baseline score at 
30-minutes and IQ; **Multivariable model is adjusted for baseline (30-minute delay score) and 
number of learning trials; **Multivariable model is adjusted for baseline (30-minute delay score) 
and age 
 
As a secondary analysis, associations between SOL and Stories % Recalled and Recognised 
from 30-minutes to 1-week were examined. Due to the small sample size and the 
potential issue of multiple testing, this analysis is exploratory and should be interpreted 
with caution. Therefore, general associations are described but p-values are not provided. 
In separate multivariable models, adjusting for baseline, IQ and number of learning trials, 
SOL was found to be associated with Stories % Recalled from 30-minutes to 1-week. This 
effect was not found for Stories % Recognition score. Adjusting for age as well as baseline, 
SOL showed no evidence of association with either Stories % Recall or Recognition.  
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4. Discussion 
 
The present study aimed to investigate whether there was evidence of a relationship 
between sleep and rate of forgetting in children with GGE, using actigraphy and 
neuropsychological memory tests as outcome measures. The study was not able to 
achieve statistical power within the timeframe provided, and therefore results presented 
have to be considered with caution but will be discussed in relation to the hypotheses 
and relevant theory.  
 
4.1 Main Findings  
 
Contrary to the first hypothesis, there was no evidence of linear relationships between SE 
or TST and rate of forgetting on either the Stories or Word Lists memory tests. This 
finding is consistent with Ashworth et al [18] who found no statistically significant 
correlation between SE or TST and initial or delayed recall in typically developing children. 
Similarly, Fitzgerald et al [21] found that SE was not related to the percentage of 
information lost between 30-minutes and 1-day on a word memory test.  However, unlike 
Ashworth et al. [18], the current study did find relationships between SOL, WASO and 
rate of forgetting. Evidence for a relationship between sleep disturbance and rate of 
forgetting was mixed. Higher levels of SOL were associated with a higher rate of 
forgetting for recall and recognition on the Word Lists test, with a moderate to large 
effect size. SOL was found to be a predictive factor for rate of forgetting on the Word Lists 
test, with a large effect size. On the Stories test, no linear relationships were found with 
SOL in the correlation analysis. However, exploratory regression analysis revealed SOL to 
be a predictive factor for rate of forgetting for recall on the Stories tests, when baseline, 
IQ and number of learning trials were controlled for, with a moderate effect size.  
 
These results provide some evidence that children with GGE who take longer to transition 
from wakefulness to sleep have a higher rate of forgetting for recalling and recognising 
previously learned verbal information.  This finding is consistent with other studies 
suggesting that learning and memory consolidation can take place over extended periods, 
and sleep disruption plays a fundamental role in these neurophysiological and 
neurochemical processes [22].  
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However, contrary to our second hypothesis, higher levels of WASO were associated with 
a lower rate of forgetting for recall on the Word Lists test, with a moderate effect size. 
Due to the small heterogeneous sample, it is suspected the latter result is due to bias. 
Replication with a larger sample would be required to confirm this was not typical of the 
wider population. The findings examining the relationship between sleep and forgetting 
suffer from the same limitations as previous studies failing to demonstrate group effects 
due to small sample size [23].  
 
In relation to the number of learning trials to reach criterion, there was no evidence of 
significant correlations with SE, TST or SOL. For sleep disturbance, there was an 
association between higher levels of WASO and a higher number of learning trials 
required on the Word Lists test, with a moderate effect size. These results suggest there is 
no significant relationship between sleep and learning efficiency for these particular tests.  
 
Children were found to have a higher rate of forgetting on the Word Lists test compared 
to the Stories test. This difference in performance may be related to the different 
methods of learning on each test, i.e. repeated presentations and rehearsal of Stories 
until criterion was met and selective reminding on Word Lists until criterion was met. 
With the first method, repeated presentations of the stories could have potentially 
resulted in the material being over-learnt, meaning that forgetting was possibly masked 
by ceiling effects in the current sample [2]. Presenting only non-remembered items at 
each trial during selective reminding on Word Lists may have avoided this. There is also 
more context in the Stories test to trigger a ‘recall cascade’, as opposed to the unrelated 
words in the list learning. Interestingly, more efficient learners recalled more at 30-
minutes on both the Stories and Word Lists tests but did not maintain this at 1-week.  On 
the Word Lists test only an increase in number of learning trials was associated with a 
lower rate of forgetting.  
 
A comparison of group means indicated that the current sample had poorer memory than 
a healthy sample and TLE sample, as measured by subjective parental report [33]. This 
may indicate a self-selection bias of the sample, as parents who felt their children had 
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more memory difficulties or were concerned about their child's memory may have been 
more likely to participate than those without concerns. It is also of note that our 
participants had a median IQ of 88, falling within the lower end of the average range, with 
12/19 with an IQ ≤89 falling within the low average range [31]. This is in contrast to other 
AF studies using CYP e.g. Davidson et al [13] had an epilepsy group mean IQ of 99, whilst 
Gascoigne et al [15] had an epilepsy group mean IQ of 102. Over half of parents reported 
that their children had sleep disturbance above the cut-off score on the CSHQ and 
indicated problematic sleep behaviours. A higher group mean of children's self-report of 
sleep on the SSR was found in the current sample, compared to a healthy sample [36]. 
This indicates that the children in the current sample perceive themselves to have poorer 
sleep than this population.  
 
4.2 Clinical Implications 
 
The present study provides evidence that there is an acceptable level of agreement 
between sleep diaries completed by children and parents and actigraphy for measuring 
time in bed, total sleep time and sleep efficiency. This is a helpful finding as clinically 
objective sleep measures such as actigraphy are often not available when implementing 
sleep interventions and sleep diaries have to be relied upon for a baseline and follow up 
measure of sleep. It should be noted that self-reported estimates from the sleep diaries 
were greater than the actigraphy outcomes. Over-estimation of sleep efficiency in 
adolescents is likely to be the result of disregarding the amount of time spent awake in 
bed. This finding is consistent with the existing literature [39]. Nevertheless, sleep diaries 
could be a cost effective alternative to actigraphy and polysomnography for larger 
samples.  
 
4.3 Limitations 
 
Results from the present study and the conclusions drawn from these should be 
interpreted with caution for several reasons. The sample size is modest and did not meet 
the predicted numbers based on the power calculation. It may be that due to the complex 
nature of the seizure disorders, impact on intellectual abilities and other confounding 
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variables inherent in using clinical samples such as that used in the present study, 
examination of sleep and learning requires significantly larger samples to detect what 
may be modest effects. 
 
The current study contributes to the early stages of exploring the factors related to 
forgetting in children with GGE. However, due to the execution of multiple correlations 
and regression analysis with an underpowered sample, the results can only be 
interpreted tentatively.  
 
While actigraphy has been previously validated against PSG [40], it is not considered the 
gold-standard technique for assessment of sleep. However, actigraphy is more cost-
effective than PSG and as it is less invasive, it can allow for individuals to sleep more 
comfortably and naturally in a familiar environment as opposed to a hospital, as is usually 
required when using PSG.  
 
4.4 Future Research 
 
Future research utilising a much larger sample size would enable use of further regression 
analysis that could explore in more detail the relative contribution of different variables 
and move closer to determining causal factors in forgetting in children with GGE. Given 
the heterogeneity of the current sample, researchers may wish to consider using a higher 
IQ cut-off score such as +- 1sd from the population norm, and use designs enabling 
seizure severity/frequency to be more accurately factored into the analyses. Future 
research should consider the advantage of using a research design including a healthy 
control group matched for age, IQ, SES and learning efficiency as suggested in a recent 
review [2]. This would allow for a comparison of rate of forgetting and sleep parameters 
in addition to exploring the relationship between the two.  
 
4.5 Conclusion 
 
In conclusion, while limited evidence is provided that sleep disturbance is associated with 
rate of forgetting in children with GGE, there was no evidence of an association between 
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sleep efficiency or sleep duration and rate of forgetting. More research is necessary to 
determine if these findings apply to the wider population or whether they are influenced 
by the small sample. Research that incorporates a control group is required before 
conclusions can be made with confidence regarding whether having epilepsy impacts on 
the relationship between sleep and rate of forgetting.  
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Abstract 
 
In order to enhance or develop clinical practice, reflective practice involves applying 
knowledge gained through one's own experience. This reflective account focuses on the 
thoughts and feelings I experienced while participating in a service user drama group on 
placement. I then go on to discuss how it impacted on my individual work with clients. I 
draw upon Gibbs' model of reflection (1988) to guide my reflections but rather than use 
this as a prescriptive structure, I follow a more natural train of thought. I refer to past 
experiences which have influenced my current practice, in addition to supervision and 
personal study and reading. The group experience prompted me to think more widely 
about boundaries and power dynamics in therapy and how my understanding of these 
has changed over time. Finally I discuss the process of writing this reflective account and 
areas I think I need to develop to further my learning. It has provided me with an 
opportunity to think about my own practice and to develop insight into my ways of 
working, impacting on my professional development.  
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Abstract 
 
Reflection on professional development over time is an essential undertaking of the 
reflective scientist-practitioner. The following reflective account documents my 
experiences of research since beginning my study of psychology. I then consider the 
potential ways research could feature in my career as a clinical psychologist in the future 
and how this relates to professional guidelines and job roles. I use Rolfe, Freshwater and 
Jasper’s (2001) reflective model to structure my discussion of my thoughts and feelings 
around the role of research in clinical psychology. To conclude I reflect of the process of 
writing this reflective account and the purpose of reflective practice.  
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Appendix 1.1 Epilepsy and Behavior Guide for Authors 
 
GUIDE FOR AUTHORS 
. 
 
INTRODUCTION 
Epilepsy & Behavior has been, and still is, the fastest-growing international journal 
since its launch in 2000. Epilepsy & Behavior is uniquely devoted to the rapid 
dissemination of the most current information available on the behavioral aspects of 
seizures and epilepsy. 
 
Epilepsy & Behavior presents original peer-reviewed articles based on laboratory and 
clinical research. Topics are drawn from a variety of fields, including clinical neurology, 
neurosurgery, neuropsychiatry, neuropsychology, neurophysiology, 
neuropharmacology, and neuroimaging. 
 
Epilepsy & Behavior publishes papers on the study of: 
• Localization of ictal and postictal behaviours 
• Neuroendocrine aspects of epilepsy 
• Psychiatric and psychosocial aspects of epilepsy 
• Behavioral aspects of epilepsy surgery 
• Cognitive and affective effects of seizure treatment 
• Functional imaging 
• Animal models 
 
Types of article 
 
Epilepsy & Behavior publishes the following types of articles: 
• Original research articles (both clinical and laboratory research) 
• Reviews 
• Editorials 
• Brief communications 
• Letters 
• Book reviews 
• Calendar of events 
 
Please note: From 1st September 2012 Epilepsy & Behavior will stop 
accepting Case 
Reports for publication in the journal. From this date authors who submit to 
Epilepsy & 
Behavior will be offered a transfer or asked to resubmit their Case Reports to 
its new sister 
journal, Epilepsy & Behavior Case Reports. 
 
Contact details for submission 
Authors should submit their articles electronically at: http://ees.elsevier.com/eb. 
 
BEFORE YOU BEGIN 
 
Ethics in publishing 
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For information on Ethics in publishing and Ethical guidelines for journal publication 
see 
http://www.elsevier.com/publishingethics and http://www.elsevier.com/journal-
authors/ethics. 
 
Human and animal rights 
If the work involves the use of animal or human subjects, the author should ensure 
that the work described has been carried out in accordance with The Code of Ethics of 
the World Medical Association (Declaration of Helsinki) for experiments involving 
humans 
http://www.wma.net/en/30publications/10policies/b3/index.html; EU Directive 
2010/63/EU for animal experiments 
http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm; 
Uniform Requirements for manuscripts submitted to Biomedical journals 
http://www.icmje.org. 
 
Authors should include a statement in the manuscript that informed consent was 
obtained for experimentation with human subjects. The privacy rights of human 
subjects must always be observed. 
 
Conflict of interest 
All authors are requested to disclose any actual or potential conflict of interest 
including any financial, personal or other relationships with other people or 
organizations within three years of beginning the submitted work that could 
inappropriately influence, or be perceived to influence, their work. See also 
http://www.elsevier.com/conflictsofinterest. Further information and an example of a 
Conflict of Interest form can be found at: 
http://help.elsevier.com/app/answers/detail/a_id/286/p/7923. 
 
Submission declaration and verification 
Submission of an article implies that the work described has not been published 
previously (except in the form of an abstract or as part of a published lecture or 
academic thesis or as an electronic preprint, see 
http://www.elsevier.com/sharingolicy), that it is not under consideration for 
publication elsewhere, that its publication is approved by all authors and tacitly or 
explicitly by the responsible authorities where the work was carried out, and that, if 
accepted, it will not be published elsewhere in the same form, in English or in any 
other language, including electronically without the written consent of the copyright-
holder. To verify originality, your article may be checked by the originality detection 
service CrossCheck http://www.elsevier.com/editors/plagdetect. 
 
Changes to authorship 
This policy concerns the addition, deletion, or rearrangement of author names in the 
authorship of accepted manuscripts: Before the accepted manuscript is published in an 
online issue: Requests to add or remove an author, or to rearrange the author names, 
must be sent to the Journal Manager from the corresponding author of the accepted 
manuscript and must include: (a) the reason the name should be added or removed, 
or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from 
all authors that they agree with the addition, removal or rearrangement. In the case 
of addition or removal of authors, this includes confirmation from the author being 
added or removed. Requests that are not sent by the corresponding author will be 
forwarded by the Journal Manager to the corresponding author, who must follow the 
procedure as described above. Note that: (1) Journal Managers will inform the Journal 
Editors of any such requests and (2) publication of the accepted manuscript in an 
online issue is suspended until authorship has been agreed. After the accepted 
manuscript is published in an online issue: Any requests to add, delete, or rearrange 
author names in an article published in an online issue will follow the same policies as 
noted above and result in a corrigendum. 
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Copyright 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing 
Agreement' (for more information on this and copyright, see 
http://www.elsevier.com/copyright). An e-mail will be sent to the corresponding 
author confirming receipt of the manuscript together with a 'Journal Publishing 
Agreement' form or a link to the online version of this agreement. Subscribers may 
reproduce tables of contents or prepare lists of articles including abstracts for internal 
circulation within their institutions. Permission of the Publisher is required for resale or 
distribution outside the institution and for all other derivative works, including 
compilations and translations (please consult http://www.elsevier.com/permissions). 
If excerpts from other copyrighted works are included, the author(s) must obtain 
written permission from the copyright owners and credit the source(s) in the article. 
Elsevier has preprinted forms for use by authors in these cases: please consult 
http://www.elsevier.com/permissions. For open access articles: Upon acceptance of 
an article, authors will be asked to complete an 'Exclusive License Agreement' (for 
more information see http://www.elsevier.com/OAauthoragreement). Permitted third 
party reuse of open access articles is determined by the author's choice of user license 
(see http://www.elsevier.com/openaccesslicenses). 
 
Author rights 
As an author you (or your employer or institution) have certain rights to reuse your 
work. For more information see http://www.elsevier.com/copyright. 
 
Role of the funding source 
You are requested to identify who provided financial support for the conduct of the 
research and/or preparation of the article and to briefly describe the role of the 
sponsor(s), if any, in study design; in the collection, analysis and interpretation of 
data; in the writing of the report; and in the decision to submit the article for 
publication. If the funding source(s) had no such involvement then this should be 
stated. 
 
Funding body agreements and policies 
Elsevier has established a number of agreements with funding bodies which allow 
authors to comply with their funder's open access policies. Some authors may also be 
reimbursed for associated publication fees. To learn more about existing agreements 
please visit http://www.elsevier.com/fundingbodies. 
 
After acceptance, open access papers will be published under a noncommercial 
license. For authors requiring a commercial CC BY license, you can apply after your 
manuscript is accepted for publication. 
 
Open access 
This journal offers authors a choice in publishing their research: 
Open access 
• Articles are freely available to both subscribers and the wider public with permitted 
reuse 
• An open access publication fee is payable by authors or on their behalf e.g. by their 
research funder or institution 
Subscription 
• Articles are made available to subscribers as well as developing countries and 
patient groups through our universal access programs 
(http://www.elsevier.com/access). 
• No open access publication fee payable by authors. 
Regardless of how you choose to publish your article, the journal will apply the same 
peer review criteria and acceptance standards. 
For open access articles, permitted third party (re)use is defined by the following 
Creative Commons user licenses: 
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Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) 
For non-commercial purposes, lets others distribute and copy the article, and to 
include in a collective work (such as an anthology), as long as they credit the 
author(s) and provided they do not alter or modify the article. 
The open access publication fee for this journal is USD 2200, excluding taxes. Learn 
more about Elsevier's pricing policy: http://www.elsevier.com/openaccesspricing. 
 
Language (usage and editing services) 
Please write your text in good English (American or British usage is accepted, but not 
a mixture of these). Authors who feel their English language manuscript may require 
editing to eliminate possible grammatical or spelling errors and to conform to correct 
scientific English may wish to use the English Language Editing service available from 
Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit our 
customer support site (http://support.elsevier.com) for more information. 
 
Submission 
Our online submission system guides you stepwise through the process of entering 
your article details and uploading your files. The system converts your article files to a 
single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are 
required to typeset your article for final publication. All correspondence, including 
notification of the Editor's decision and requests for revision, is sent by e-mail. 
Submit your article 
Please submit your article via http://ees.elsevier.com/eb. 
 
PREPARATION 
 
Use of word processing software 
It is important that the file be saved in the native format of the word processor used. 
The text should be in single-column format. Keep the layout of the text as simple as 
possible. Most formatting codes will be removed and replaced on processing the 
article. In particular, do not use the word processor's options to justify text or to 
hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. 
When preparing tables, if you are using a table grid, use only one grid for each 
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to 
align columns. 
The electronic text should be prepared in a way very similar to that of conventional 
manuscripts (see also the Guide to Publishing with Elsevier: 
http://www.elsevier.com/guidepublication). Note that source files of figures, tables 
and text graphics will be required whether or not you embed your figures in the text. 
See also the section on Electronic artwork. To avoid unnecessary errors you are 
strongly advised to use the 'spell-check' and 'grammar-check' functions of your word 
processor. 
 
Article structure 
AUTHOR INFORMATION PACK 21 Feb 2015 www.elsevier.com/locate/yebeh 7 
Subdivision - numbered sections 
Divide your article into clearly defined and numbered sections. Subsections should be 
numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section 
numbering). Use this numbering also for internal cross-referencing: do not just refer 
to 'the text'. Any subsection may be given a brief heading. Each heading should 
appear on its own separate line. 
Introduction 
State the objectives of the work and provide an adequate background, avoiding a 
detailed literature survey or a summary of the results. 
Material and methods 
Provide sufficient detail to allow the work to be reproduced. Methods already published 
should be indicated by a reference: only relevant modifications should be described. 
Results 
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Results should be clear and concise. 
Discussion 
The Discussion section should explore the significance of the results of the work, not 
repeat them. 
Results and Discussion should be separate and may be organized into subheadings. 
Avoid extensive citations and discussion of published literature. 
Conclusions 
The main conclusions of the study may be presented in a short Conclusions section, 
which may stand alone or form a subsection of a Discussion or Results and Discussion 
section. 
 
Essential title page information 
• Title. Concise and informative. Titles are often used in information-retrieval 
systems. Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Where the family name may be ambiguous (e.g., 
a double name), please indicate this clearly. Present the authors' affiliation addresses 
(where the actual work was done) below the names. Indicate all affiliations with a 
lower-case superscript letter immediately after the author's name and in front of the 
appropriate address. Provide the full postal address of each affiliation, including the 
country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that the e-mail 
address is given and that contact details are kept up to date by the 
corresponding author. 
• Present/permanent address. If an author has moved since the work described in 
the article was done, or was visiting at the time, a 'Present address' (or 'Permanent 
address') may be indicated as a footnote to that author's name. The address at which 
the author actually did the work must be retained as the main, affiliation address. 
Superscript Arabic numerals are used for such footnotes. 
Please note that proprietary names for drugs should not be used in the article title. 
 
Abstract 
A concise and factual abstract is required. The abstract should state briefly the 
purpose of the research, the principal results and major conclusions. An abstract is 
often presented separately from the article, so it must be able to stand alone. For this 
reason, References should be avoided, but if essential, then cite the author(s) and 
year(s). Also, non-standard or uncommon abbreviations should be avoided, but if 
essential they must be defined at their first mention in the abstract itself. 
 
Graphical abstract 
Although a graphical abstract is optional, its use is encouraged as it draws more 
attention to the online article. The graphical abstract should summarize the contents 
of the article in a concise, pictorial form designed to capture the attention of a wide 
readership. Graphical abstracts should be submitted as a separate file in the online 
submission system. Image size: Please provide an image with a minimum of 531 × 
1328 pixels (h × w) or proportionally more. The image should be readable at a size of 
5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, 
PDF or MS Office files. See http://www.elsevier.com/graphicalabstracts for examples. 
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the 
best presentation of their images and in accordance with all technical requirements: 
Illustration Service. 
 
Highlights 
Highlights are a short collection of bullet points that convey the core findings of the 
article. Highlights are optional and should be submitted in a separate editable file in 
the online submission system. Please use 'Highlights' in the file name and include 3 to 
5 bullet points (maximum 85 characters, including spaces, per bullet point). See 
http://www.elsevier.com/highlights for examples. Highlights are mandatory for 
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Original Reports and Reviews only. They are optional but encouraged for all other 
article types. 
 
Keywords 
Immediately after the abstract, provide a maximum of 6 keywords, using American 
spelling and avoiding general and plural terms and multiple concepts (avoid, for 
example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly 
established in the field may be eligible. These keywords will be used for indexing 
purposes. 
 
Abbreviations 
Define abbreviations that are not standard in this field in a footnote to be placed on 
the first page of the article. Such abbreviations that are unavoidable in the abstract 
must be defined at their first mention there, as well as in the footnote. Ensure 
consistency of abbreviations throughout the article. 
 
Acknowledgements 
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the 
title or otherwise. List here those individuals who provided help during the research 
(e.g., providing language help, writing assistance 
or proof reading the article, etc.). 
 
Units 
Follow internationally accepted rules and conventions: use the international system of 
units (SI). If other units are mentioned, please give their equivalent in SI. 
 
Database linking 
Elsevier encourages authors to connect articles with external databases, giving their 
readers one click access to relevant databases that help to build a better 
understanding of the described research. Please refer to relevant database identifiers 
using the following format in your article: Database: xxxx (e.g., TAIR: AT1G01020; 
CCDC: 734053; PDB: 1XFN). See http://www.elsevier.com/databaselinking for more 
information and a full list of supported databases. 
 
Math formulae 
Please submit math equations as editable text and not as images. Present simple 
formulae in line with normal text where possible and use the solidus (/) instead of a 
horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be 
presented in italics. Powers of e are often more conveniently denoted by exp. Number 
consecutively any equations that have to be displayed separately from the text (if 
referred to explicitly in the text). 
 
Footnotes 
Footnotes should be used sparingly. Number them consecutively throughout the 
article. Many word processors can build footnotes into the text, and this feature may 
be used. Otherwise, please indicate the position of footnotes in the text and list the 
footnotes themselves separately at the end of the article. Do not include footnotes in 
the Reference list. 
 
Artwork 
Electronic artwork 
General points 
• Make sure you use uniform lettering and sizing of your original artwork. 
• Embed the used fonts if the application provides that option. 
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, 
Symbol, or 
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use fonts that look similar. 
• Number the illustrations according to their sequence in the text. 
• Use a logical naming convention for your artwork files. 
• Provide captions to illustrations separately. 
• Size the illustrations close to the desired dimensions of the published version. 
• Submit each illustration as a separate file. 
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/artworkinstructions 
 
You are urged to visit this site; some excerpts from the detailed information 
are given here. 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, 
PowerPoint, Excel) then please supply 'as is' in the native document format. 
Regardless of the application used other than Microsoft Office, when your electronic 
artwork is finalized, please 'Save as' or convert the images to one of the following 
formats (note the resolution requirements for line drawings, halftones, and 
line/halftone combinations given below): 
EPS (or PDF): Vector drawings, embed all used fonts. 
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 
dpi. 
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a 
minimum of 1000 dpi. 
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a 
minimum of 500 dpi. 
 
Please do not: 
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these 
typically have a 
low number of pixels and limited set of colors; 
• Supply files that are too low in resolution; 
• Submit graphics that are disproportionately large for the content. 
Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS 
(or PDF), or MS Office files) and with the correct resolution. If, together with your 
accepted article, you submit usable color figures then Elsevier will ensure, at no 
additional charge, that these figures will appear in color online (e.g., ScienceDirect 
and other sites) regardless of whether or not these illustrations are reproduced in 
color in the printed version. For color reproduction in print, you will receive 
information regarding the costs from Elsevier after receipt of your accepted 
article. Please indicate your preference for color: in print or online only. For further 
information on the preparation of electronic artwork, please see 
http://www.elsevier.com/artworkinstructions. 
Please note: Because of technical complications that can arise by converting color 
figures to 'gray scale' (for the printed version should you not opt for color in print) 
please submit in addition usable black and white versions of all the color illustrations. 
Color figures for exclusive use as cover illustration may be submitted by authors 
who are also submitting a manuscript for consideration. These figures should relate to 
the manuscript being submitted as well as the larger scope and focus of Epilepsy & 
Behavior. 
 
Illustration services 
Elsevier's WebShop (http://webshop.elsevier.com/illustrationservices) offers 
Illustration Services to authors preparing to submit a manuscript but concerned about 
the quality of the images accompanying their article. Elsevier's expert illustrators can 
produce scientific, technical and medicalstyle images, as well as a full range of charts, 
tables and graphs. Image 'polishing' is also available, where our illustrators take your 
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image(s) and improve them to a professional standard. Please visit the website to find 
out more. 
Figure captions 
Ensure that each illustration has a caption. Supply captions separately, not attached to 
the figure. A caption should comprise a brief title (not on the figure itself) and a 
description of the illustration. Keep text in the illustrations themselves to a minimum 
but explain all symbols and abbreviations used. 
 
Tables 
Please submit tables as editable text and not as images. Tables can be placed either 
next to the relevant text in the article, or on separate page(s) at the end. Number 
tables consecutively in accordance with their appearance in the text and place any 
table notes below the table body. Be sparing in the use of tables and ensure that the 
data presented in them do not duplicate results described elsewhere in the article. 
Please avoid using vertical rules. 
 
References 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list 
(and vice versa). Any references cited in the abstract must be given in full. 
Unpublished results and personal communications are not recommended in the 
reference list, but may be mentioned in the text. If these references are included in 
the reference list they should follow the standard reference style of the journal and 
should include a substitution of the publication date with either 'Unpublished results' 
or 'Personal communication'. Citation of a reference as 'in press' implies that the item 
has been accepted for publication. 
Web references 
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed 
separately (e.g., after the reference list) under a different heading if desired, or can 
be included in the reference list. 
References in a special issue 
Please ensure that the words 'this issue' are added to any references in the list (and 
any citations in the text) to other articles in the same Special Issue. 
Reference style 
Text: Indicate references by number(s) in square brackets in line with the text. The 
actual authors can be referred to, but the reference number(s) must always be given. 
List: Number the references (numbers in square brackets) in the list in the order in 
which they appear in the text. 
Examples: 
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the electronic version of your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. 
Please supply 'stills' with your files: you can choose any frame from the video or 
animation or make a separate image. These will be used instead of standard icons and 
will personalize the link to your video data. For more detailed instructions please visit 
our video instruction pages at 
http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot 
be embedded in the print version of the journal, please provide text for both the 
electronic and the print version for the portions of the article that refer to this content. 
 
AudioSlides 
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown 
next to the online article on ScienceDirect. This gives authors the opportunity to 
summarize their research in their own words and to help readers understand what the 
paper is about. More information and examples are available at 
http://www.elsevier.com/audioslides. Authors of this journal will automatically receive 
an invitation e-mail to create an AudioSlides presentation after acceptance of their 
paper. 
 
Supplementary data 
Elsevier accepts electronic supplementary material to support and enhance your 
scientific research. 
Supplementary files offer the author additional possibilities to publish supporting 
applications, highresolution images, background datasets, sound clips and more. 
Supplementary files supplied will be published online alongside the electronic version 
of your article in Elsevier Web products, including 
ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted 
material is directly usable, please provide the data in one of our recommended file 
formats. Authors should submit the material in electronic format together with the 
article and supply a concise and descriptive caption for each file. For more detailed 
instructions please visit our artwork instruction pages at 
http://www.elsevier.com/artworkinstructions. 
 
3D neuroimaging 
You can enrich your online articles by providing 3D neuroimaging data in NIfTI format. 
This will be visualized for readers using the interactive viewer embedded within your 
article, and will enable them to: browse through available neuroimaging datasets; 
zoom, rotate and pan the 3D brain reconstruction; cut through the volume; change 
opacity and color mapping; switch between 3D and 
2D projected views; and download the data. The viewer supports both single (.nii) and 
dual (.hdr and .img) NIfTI file formats. Recommended size of a single uncompressed 
dataset is 100 MB or less. Multiple datasets can be submitted. Each dataset will have 
to be zipped and uploaded to the online submission system via the '3D neuroimaging 
data' submission category. Please provide a short informative description for each 
dataset by filling in the 'Description' field when uploading a dataset. 
 
 
80 
 
Note: all datasets will be available for downloading from the online article on 
ScienceDirect. If you have concerns about your data being downloadable, please 
provide a video instead. For more information see: 
http://www.elsevier.com/3DNeuroimaging. 
 
Submission checklist 
The following list will be useful during the final checking of an article prior to sending it 
to the journal for review. Please consult this Guide for Authors for further details of 
any item. 
Ensure that the following items are present: 
One author has been designated as the corresponding author with contact details: 
• E-mail address 
• Full postal address 
All necessary files have been uploaded, and contain: 
• Keywords 
• All figure captions 
• All tables (including title, description, footnotes) 
Further considerations 
• Manuscript has been 'spell-checked' and 'grammar-checked' 
• References are in the correct format for this journal 
• All references mentioned in the Reference list are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources 
(including the 
Internet) 
Printed version of figures (if applicable) in color or black-and-white 
• Indicate clearly whether or not color or black-and-white in print is required. 
• For reproduction in black-and-white, please supply black-and-white versions of the 
figures for printing purposes. 
For any further information please visit our customer support site at 
http://support.elsevier.com. 
 
AFTER ACCEPTANCE 
 
Use of the Digital Object Identifier 
The Digital Object Identifier (DOI) may be used to cite and link to electronic 
documents. The DOI consists of a unique alpha-numeric character string which is 
assigned to a document by the publisher upon the initial electronic publication. The 
assigned DOI never changes. Therefore, it is an ideal medium for citing a document, 
particularly 'Articles in press' because they have not yet received their full 
bibliographic information. Example of a correctly given DOI (in URL format; here an 
article in the journal Physics Letters B): 
http://dx.doi.org/10.1016/j.physletb.2010.09.059 
When you use a DOI to create links to documents on the web, the DOIs are 
guaranteed never to change. 
 
Online proof correction 
Corresponding authors will receive an e-mail with a link to our online proofing system, 
allowing annotation and correction of proofs online. The environment is similar to MS 
Word: in addition to editing text, you can also comment on figures/tables and answer 
questions from the Copy Editor. Web-based proofing provides a faster and less error-
prone process by allowing you to directly type your corrections, eliminating the 
potential introduction of errors. If preferred, you can still choose to annotate and 
upload your edits on the PDF version. All instructions for proofing will be given in the 
e-mail we send to authors, including alternative methods to the online version and 
PDF. We will do everything possible to get your article published quickly and 
accurately. Please use this proof only for checking the typesetting, editing 
completeness and correctness of the text, tables and figures. Significant changes to 
the article as accepted for publication will only be considered at this stage with 
 
 
81 
 
permission from the Editor.It is important to ensure that all corrections are sent back 
to us in one communication. Please check carefully before replying, as inclusion of any 
subsequent corrections cannot be guaranteed. Proofreading is solely your 
responsibility. 
 
Offprints 
The corresponding author, at no cost, will be provided with a personalized link 
providing 50 days free access to the final published version of the article on 
ScienceDirect. This link can also be used for sharing via email and social networks. For 
an extra charge, paper offprints can be ordered via the offprint order form which is 
sent once the article is accepted for publication. Both corresponding and co-authors 
may order offprints at any time via Elsevier's 
WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring 
printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' 
service to collate multiple articles within a single cover 
(http://webshop.elsevier.com/myarticleservices/booklets). 
 
AUTHOR INQUIRIES 
You can track your submitted article at 
http://help.elsevier.com/app/answers/detail/a_id/89/p/8045/. 
You can track your accepted article at http://www.elsevier.com/trackarticle. You are 
also welcome to contact Customer Support via http://support.elsevier.com. 
 
© Copyright 2014 Elsevier | http://www.elsevier.com 
 
 
82 
 
 
Appendix 1.2 Crowe Critical Appraisal Tool 
 
 
 
 
 
83 
  
 
 
84 
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Austin et al. (2002) 4 5 2 0 4 2 1 2 20 50 
Blocher et al. (2013) 4 5 3 3 4 5 4 5 33 82.5 
Conant et al. (2008) 4 5 2 1 2 1 2 2 19 47.5 
Carbone et al. (2014) 4 4 3 3 2 3 3 4 26 65 
Eom et al. (2014) 4 4 3 1 3 2 2 5 24 60 
Frizzel et al. (2011) 4 4 2 1 2 3 4 4 24 60 
Glueckauf et al. 2002 2 5 3 1 4 1 4 4 24 60 
Jantzen et al. (2009) 4 5 3 5 5 3 5 2 31 77.5 
Lewis et al. (1990, 1991) 5 5 4 3 2 2 2 3 26 65 
Martinovic et al. (2006) 4 4 4 3 4 3 4 5 31 77.5 
Modi et al. (2013) 4 5 3 2 3 5 3 3 28 70 
Rau et al. (2006) 4 5 3 2 2 1 4 4 25 62.5 
Shore et al. (2008) 2 4 3 3 3 4 3 5 27 67.5 
Snead et al. (2004) 4 5 2 1 3 2 3 3 23 57.5 
Stafstrom et al. (2012) 3 5 1 1 4 3 1 2 20 50 
Tiffenberg et al. (2000) 5 4 2 2 4 2 2 3 24 60 
Wagner et al. 2010 4 4 2 4 3 3 3 4 27 67.5 
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Appendix 1.4 References for Table 1 Study Outcome Measures 
 
AKEQ - The Adolescents’ Knowledge of Epilepsy Questionnaire (Baker GA, Spector S, 
McGrath Y, Soteriou H. Impact of epilepsy in adolescence: a UK controlled study. Epilepsy 
Behav 2005; 6: 556–62.) 
 
APGAR - Measure of family functioning (Smilkstein G, Ashworth C, Montano, D. Validity 
and reliability of the family APGAR as a test of family function. The Journal of family 
practice 1982;15: 303-11.) 
 
BDI - Beck Depression Inventory (Beck AT, Ward CH, Mendelson M. An inventory for 
measuring depression. Arch Gen Psychiatry 1961;4: 861–71.) 
 
CATIS - Child Attitude Toward Illness Scale (Austin JK, Huberty TJ. Development of the 
child attitude toward illness scale. Journal of Pediatric Psychology1993;18: 467–80.) 
 
CBCL - Child Behavior Checklist (Achenbach TM, Rescorla LA. Manual for the ASEBA 
school-age forms and profiles. Burlington, VT: University of Vermont, Research Center for 
Children, Youth, & Families; 2001.) 
 
CDI  - Child Depression Inventory (Kovacs M. Children's depression inventory (CDI) 
manual. New York: Multi-Health Systems, Inc; 1992.) 
 
CDI-K - Children's Depression Inventory, Korean Version (Kim EK, Yang JW, Chung YS, 
Hong SD, Kim JH. Factor structure of the Children's Depression Inventory (CDI) in children 
and adolescent. Korean Journal of Clinical Psychology 2005;24: 693–707.) 
 
CAT - Comprehensive Attention Test (Yoo H, Lee J S HK, Park EH, Jung J, Kim BN, et al. 
Standardization of the Comprehensive Attention Test for the Korean children and 
adolescents. Journal of Korean Academic Child and Adolescent Psychiatry 2009;20: 68–
75.) 
 
CCTT - Children's Color Trails Test (Llorente AM, Voigt RG, Williams J, Frailey JK, Satz P, 
D'Elia LF. Children's Color Trails Test 1 & 2: test–retest reliability and factorial validity. 
Clinical Neuropsychology 2009;23: 645–60.) 
 
CHLCS – Child Health Locus of Control Scale (Parcel CS, Meyer MP. Development of an 
instrument to measure children's health locus of control. Health Educ Monogr 1978;6: 
149-59. 
 
CHQ - Child Health Questionnaire (Landgraf JM, Abetz L, Ware JE. The Child Health 
Questionnaire (CHQ): A user’s manual. Boston: New England Medical Centre; 1999.) 
 
CES-D - Centre for Epidemiological Study on Depression Scale (Radloff LS. TheCES-Dscale: 
a self-report depression scale for research in the general population. Appl Psychol Meas 
1977;1: 385–401.) 
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CHIC - Coping Health Inventory for Children (Austin JK, Patterson JM, Huberty TJ. 
Development of the Coping Health Inventory for Children. J Pediatr Nurs 1991;6: 166–74.) 
 
EKP-G - Parents-Epilepsy Knowledge Profile (Jantzen S, Muller-Godeffroy E, Hallfahrt-Krisl 
T, Aksu F, Pust B, Kohl B, Redlich A, Sperner J, Thyen U. FLIP&FLAP-a training programme 
for children and adolescents with epilepsy, and their parents. Seizure 2009;18: 478-86.) 
 
EKP-27 - Parents epilepsy-related worries questionnaire (Jantzen S, Muller-Godeffroy E, 
Hallfahrt-Krisl T, Aksu F, Pust B, Kohl B, Redlich A, Sperner J, Thyen U. FLIP&FLAP-a 
training programme for children and adolescents with epilepsy, and their parents. Seizure 
l2009;18: 478-86.) 
 
ESES -  Epilepsy Self-Efficacy Scale (DiIorio C, Faherty B, Manteuffel B, Hoeffer B, Hilbert 
GA. Self-efficacy and social support in self-management of epilepsy. West J Nurs Res 
1992;14: 292–307.) 
 
FAQ - Feasibility-Acceptability Questionnaire on Adherence Intervention (Modi AC, 
Guilfoyle SM, Rausch J. Preliminary Feasibility, Acceptability, and Efficacy of an Innovative 
Adherence Intervention for Children with newly Diagnosed Epilepsy. Journal of Paediatric 
Psychology 2013: 1-12.) 
 
HAMD - Hamilton Depression Scale (Hamilton M. Development of a rating scale for 
primary depressive illness. Br J Doc Clin Psychol 1967;6:278–96.) 
 
Harter’s Self Competency Scale (Harter S. The perceived competence scale for children. 
Child Dev 1982;53:87-97.) 
 
HRQOL - Health Related Quality of Life (Baars RM, Atherton CI, Koopman HM, Bullinger 
M, Power M. The European DISABKIDS project: development of seven condition-specific 
modules to measure health related quality of life in children and adolescents. Health and 
Quality of Life Outcomes 2005; 3:70.) 
 
HSC - Hopelessness Scale for Children (Kazdin AE, French NH, Unis AS, Esveldt-Dawson K, 
Sherick RB. Hopelessness, depression, and suicidal intent among psychiatrically disturbed 
inpatient children. J Consult Clin Psychol 1983;51: 504–10.) 
 
ISS, IFS, ICS - The family and disability assessment manual (Glueckauf RL, Webb P, 
Papandria-Long M, Rasmussen JL, Markand O, Farlow M. The Family and Disability 
Assessment System: Consistency and accuracy of judgments across coders and measures. 
Rehab Psychol 1992;37: 291–304) 
 
KINDL - Health-Related Quality of Life Questionnaire (Ravens-Sieberer U, Bullinger M. 
Assessing health related quality of life in chronically ill children with the German KINDL: 
first psychometric and content-analytical results. Quality of Life Research 1998;4: 7) 
 
Knowledge Related to Epilepsy Scale (Helgeson DC, Mittan R, Tan SY, Chayasirisobhon S. 
Sepulveda Epilepsy Education: the efficacy of a psychoeducational treatment program in 
treating medical and psychosocial aspects of epilepsy. Epilepsia 1990;31: 75–82.) 
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K-CBCL - Korea-Child Behaviour Checklist (Oh KJ, Lee HR. Development of Korean version 
of Child Behavior Checklist (K-CBCL).Seoul: Korean Research Foundation; 1997) 
 
K-QOLCE - Quality of Life in Childhood Epilepsy (Lim KH, Kim HD. Validation of a Korean 
version of the Quality of Life in Childhood Epilepsy Questionnaire (K-QOLCE). Journal of 
Korean Epilepsy Society 2002;6: 32–44.) 
 
MAACL - Multiple Affect Adjective Checklist (Zuckerman M, Lubin B. Multiple Affect 
Adjective Checklist Revised Manual. San Diego: Edits; 1965) 
 
MASC - Multidimensional Anxiety Scale for Children (March JS, Parker JDA, Sullivan K, 
Stallings P. The Multidimensional Anxiety Scale for Children (MASC): factor structure, 
reliability, and validity. Journal of the American Academy of Child Adolescent Psychiatry 
1997;36(4): 554–65.) 
 
MEMS ‘TrackCap’ - Medication Event Monitoring System (Aardex group, Sion, 
Switzerland) 
 
Parent Response to Illness Scale (Austin JK, Dunn D, Huster G, Rose D. Development of 
scales to measure psychosocial care needs of children with seizures and their parents. J 
Neurosci Nurs 1998;30: 155–60.) 
 
PCS - Psychosocial Care Scale - Parent and Child Report. (Austin JK, Dunn D, Huster GA, 
Rose DF. Development of scales to measure psychosocial care needs of children with 
seizures and their parents. J Neurosci Nurs 1998;30(3): 155–160.) 
 
PH-1 - Piers-Harris Children's Self Concept Scale (Piers EVH, Piers-Harris DS, editors. 
Children’s self-concept scale-second edition manual. 2nd ed. Los Angeles: Western 
Psychological Services; 2002) 
 
PIP – Pediatric Inventory for Parents (Streisand R, Branieck S, Tercyak KP, Kazak AE. 
Childhood illness-related parenting stress: the Pediatric Inventory for Parents. J Pediatr 
Psychol 2001;26: 155–62.) 
 
PSI - Parenting Stress Index (Abidin RR.Parenting stress index (4th ed.). Lutz, FL: PAR; 
2012.) 
 
QOLCE - Quality of Life in Childhood Epilepsy Scale (Talarska D. The usefulness of Quality 
of Life Childhood Epilepsy (QOLCE) questionnaire in evaluating the quality of life of 
children with epilepsy. Advances in medical science 2007;52(1): 191-3.) 
 
QOLIE-AD-48 - Quality of Life Inventory for Adolescents with Epilepsy (Cramer JA, 
Westbrook L, Devinsky O, Perrine K, Glassman M, Camfield C. Development of a quality of 
life inventory for adolescents: the QOLIE-AD-48. Epilepsia 1999;40: 1114–21.) 
 
QOLIE-31 - Quality of Life in epilepsy inventory (Cramer JA, Perrine K, Devinsky O, Bryant-
Comstock L, Meador K, Hermann B. Development and cross-cultural translations of 31-
item Quality of Life in Epilepsy Inventory (QUOLIE-31). Epilepsia 1998;39: 81–8.) 
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RCMAS - Revised children's manifest anxiety scale, Korean version (Chio JS, Cho SC. 
Reliability and validity of Revised Children's Manifest Anxiety Scale. Korean Journal of 
Neuropsychiatric Association 1989;14: 150–7.) 
 
RSES - The Rosenberg Self-Esteem Scale (Rosenberg M. Society and the Adolescent Self-
Image. Princeton: Princeton University Press; 1965) 
 
SCARED - Screen for Child Anxiety Related Emotional Disorders (Birmaher B, Khetarpal S, 
Brent D, Cully M, Balach L, Kaufman J, Neer SM. The Screen for Child Anxiety Related 
Emotional Disorders (SCARED): scale construction and psychometric characteristics. 
Journal of the American Academy of Child Adolescent Psychiatry 1997;36(4): 545–53.) 
 
SDQ - Strengths and Difficulties Questionnaire (Goodman R, Renfrew D, Mullick M. 
Predicting type of psychiatric disorder from Strengths and Difficulties Questionnaire (SDQ) 
scores in child mental health clinics in London and Dhaka. European Child Adolescent 
Psychiatry 2000;9: 129–34.) 
 
SSES - Seizure self-efficacy scale (Caplin D, Austin J, Dunn D, Shen J, Perkins S. 
Development of a self-efficacy scale for children and adolescents with epilepsy. Child 
Health Care 2002;31: 295–309.) 
 
SSES-C – The State Self Esteem Scale (Heatherton, T.F. and Polivy, J. Development and 
Validation of a Scale for Measuring State Self-Esteem. Journal of Personality and Social 
Psychology 60: 895-910) 
 
SSRS - Social Skills Rating System (Gresham FM, Elliott SN. Social skills rating system 
manual. Circle Pines: American Guidance Service; 1990) 
 
SSSS- Seizure Social Severity Scale (Austin JK, Dunn DW, Perkins SM, Shen J. Youth with 
epilepsy: development of a model of children's attitudes toward their condition. Child 
Health Care 2006;35: 123–40.) 
 
WAI - Working Alliance Inventory (Horvath AO, Greenberg LS (1989). Development and 
validation of the Working Alliance Inventory. Journal of Counseling Psychology 1989;36: 
223-33.) 
 
WISC-III - Wechsler Intelligence Scale (Kwak K, Choi HP, Kim C. A study for the 
standardization of the Korean Wechsler Intelligence Scale—Third Edition (WISC-III). 
Korean Journal of Developmental Psychology 2002;15: 19–33.) 
 
ZUF-8 - Client Satisfaction Questionnaire, German Version (Schmidt J, Nubling R. ZUF-8. 
Fragebogen zur Messung der Patientenzufriedenheit. In: Brahler E, Schumacher J, Strauß 
B, editors. Diagnostische Verfahren in der Psychotherapie. Gottingen: Hogrefe; 2002. p. 
392–6) 
 
 
 
 
 
 
89 
 
Appendix 2.1 Letter granting ethical approval by the North of Scotland Research Ethics 
Committee 
 
 
 
90 
 
 
 
 
91 
 
 
 
92 
 
 
 
93 
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Appendix 2.4 Letter granting site and management approval by the NHS Lothian Research 
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Appendix 2.5 Participant Invitation Letter 
   
 
 
Dear Parent/Guardian and Child,   
 
Invitation to Participate in Research Study: Learning and sleep in children 
and young people with epilepsy. 
 
As you know, I am part of a team of people who are involved in your child’s 
ongoing care. As your healthcare professional I would like to inform you of some 
new research that is being carried out.  
 
We are interested in studying the relationship between sleep and learning. We 
know that many young people with epilepsy can have sleep problems and 
therefore want to look at whether this can affect their learning during the day. We 
are asking everyone who comes to the Epilepsy Clinic at the Royal Hospital for 
Sick Children to consider taking part in a research study being carried out by Fiona 
Corrigan as part of her Doctorate in Clinical Psychology. This research may help 
us to gain knowledge on how children with epilepsy's learning could be improved.  
 
Before you and your child make up your mind, it is important for you both to 
understand what we are asking them to do and why. Please find enclosed an 
information sheet to tell you all about the study. Please read it and ask your child 
to read it as well.  
 
The study involves arranging two appointments with Fiona for your child to 
complete some tasks related to their memory. It would also involve measurement 
of your child’s sleep over a week long period using a small device like a wrist 
watch. When your child attends they will have time to find out more about the 
study and ask more questions before taking part. If your child decides they don’t 
want to take part, then they can say no and they won’t be asked anything else.  
 
Asking your child to take part in this study does not mean we think they have a 
problem with their memory or sleep. We are asking everyone who comes to clinics 
and they can say ”no” if they don’t want to take part. 
 
If they decide they want to take part after reading the information sheet, you can 
either return the form in the enclosed envelope to Fiona Corrigan, Institute of 
Health and Wellbeing, University of Glasgow, 1st floor, Administration Building, 
Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, G12 0XH or call 
Fiona Corrigan on XXXXor email at f.corrigan.1@research.gla.ac.uk 
 
If you want to ask anything else about the study you can call or email Fiona using 
the above contact details. 
 
Thank you for reading this. 
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Yours sincerely, {Insert Name here} Consultant Paediatric Neurologist  
Appendix 2.6 Participant Opt-in Form 
      
 
Learning and sleep in children and young people with epilepsy 
 
I have read the information sheets dated 15/08/14 (Version 1 Child and Version 2 Parent) 
and I would like to participate in this study. 
 
 
Name of child:_______________________________________________________ 
 
Name of parent/carer:_________________________________________________ 
 
Signed:______________________________________________________ 
 
Please contact me to arrange an appointment by: 
 
 
Email: my email address is:_____________________________________ 
 
 
 
Phone: my telephone number is:_________________________________ 
 
 
 
Post: my address is:__________________________________ 
 
__________________________________ 
 
__________________________________ 
 
Return Details: 
 
Fiona Corrigan,  
Institute of Health and Wellbeing,  
University of Glasgow,  
1st floor, Administration Building,  
Gartnavel Royal Hospital,  
1055 Great Western Road,  
Glasgow, G12 0XH  
 
or call Fiona Corrigan on XXXX 
 
or email at f.corrigan.1@research.gla.ac.uk 
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Appendix 2.7 Child Information Sheet (Age 9-12) 
      
Participant Information Sheet 
 
(To be shown and read by parent/carer if required) 
 
Learning and sleep in children and young people with epilepsy. Researcher: Fiona 
Corrigan 
 
My name is Fiona Corrigan and I am a Trainee Clinical Psychologist at the University of 
Glasgow. I am doing a project on epilepsy, sleep and learning and I am inviting you to 
take part in it. Before you decide you need to understand why the project is being done 
and what you would need to do.  
 
1.   Why is this project being done? 
I want to find out if there is a connection between learning and sleep in children with 
epilepsy.  
It may help doctors understand more about the difficulties that children with epilepsy might 
have.  
 
 
2. Why me? 
All children aged between 9 and 16 years that have epilepsy and go to the Royal Hospital 
for Sick Children (RHSC) (Glasgow or Edinburgh) have been asked to take part. 
 
3. Do I have to take part? 
No you do not, it is up to you. If you don’t want to take part, just say no.   
 
4. What will happen? 
If you would like to take part, then you and I would meet together for two appointments at 
the at the hospital you normally go to. Your Mum, Dad or carer can come with you. 
 
When we meet, I will ask you some questions about your sleep and we will do some 
learning tasks together. Between our two appointments I will ask you to wear a special 
watch like the one in the picture below. This is called an "actiwatch" and it will tell me how 
much sleep you are getting. You will be involved in the study for 8 days in total.  
 
 
 
 
 
 
 
 
5. Will my answers be private? 
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I will write down your answers to the tasks but everything you say will be kept private and 
only people working on the study will be allowed to see it. Information in the report will not 
have your name on it.   
 
6. What if I don’t want to do the research anymore? 
If you decide that you don’t want to take part even after we have started then that is okay. 
We can stop at any time for a break and you can leave with your parent/carer when you 
decide you want to leave. This will not affect the care you are getting from any doctors or 
nurses at the hospital.  
  
 
7. What happens to what the researchers find out? 
The results will be written up in a report and might go in a book or magazine about 
epilepsy that doctors read.   
 
 
If you would like to take part or have any questions then please ask your parent/carer to 
get in touch with me on: Tel: 07934157344, Email: f.corrigan.1@research.gla.ac.uk. 
Alternatively they can contact: Dr Liam Dorris, Chief Research Investigator and 
Consultant Paediatric Neuropsychologist, Fraser of Allander Neurosciences Unit (Tel: 
0141 201 0863) 
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Appendix 2.8 Child Information Sheet (Age13-16) 
      
 
Participant Information Sheet: Learning and sleep in children and young people 
with epilepsy. Researcher: Fiona Corrigan 
 
My name is Fiona Corrigan.  I am a Trainee Clinical Psychologist at the University of 
Glasgow. I would like to ask you to take part in my research project. This project is about 
sleep and memory in children and young people who have epilepsy.  It may help doctors 
understand more about the difficulties that children with epilepsy might have.  Please 
speak to your parents or guardians about this project.  If you have any questions you can 
also ask me. 
 
What is this project for? Some children with epilepsy find it harder to remember 
information over long periods of time and might forget things more easily. Sleep is also 
something that can be affected by epilepsy. I want to find out if there is a connection 
between forgetting information and sleep in children with epilepsy.  
 
Why have I been asked to take part? All children aged between 9 and 16 years that 
have epilepsy and go to the Royal Hospital for Sick Children (RHSC) (Glasgow or 
Edinburgh) have been asked to take part. 
 
Do I have to take part? No. Talk it over with your parent or guardian and decide if you 
want to take part or not. You can pull out at any time and don’t have to say why.  This will 
not affect the treatment you are getting from any doctors or nurses. 
 
If I agree to take part, what will happen next? I will arrange to meet with you and your 
parent/guardian twice at the RHSC (Glasgow or Edinburgh).  
 
What will I have to do? When we meet up I will make sure that you want to take  
part and ask you to sign a form to say you understand what taking part will involve.  
I will then ask you to do some tasks related to your memory and ask you some  
questions about your sleep. I will then give you an Actiwatch, which looks like a  
normal watch (as shown in photo) that you wear on your wrist, and show you  
how to use it to measure your sleep at home. You will wear the watch all day  
and night for seven days, it is waterproof but you can take it off while bathing  
if you want to. This meeting will take about 1 hour. I will also give your parents  
or guardians a questionnaire with questions about your sleep and memory.  
I will then meet with you at the hospital a week later to collect the Actiwatch  
and ask you some more questions. This should take about 15 minutes. You will be 
involvedin the study for 8 days in total.  
 
Will my answers be private? All the information you give me will be kept private and only 
people working on the study will be allowed to see it.  Information in the report will not 
have your name on it.   
 
What will happen to the results? The results will be written up in a report and might be 
published in a book or magazine about epilepsy that doctors read.  You can get a copy of 
a brief summary from me (Fiona Corrigan). 
 
Thank you very much for reading this leaflet. 
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For More Information Please Contact:  
• Fiona Corrigan, Trainee Clinical Psychologist, Department of Psychological Medicine, 
Gartnavel Royal Hospital (Tel: 07934157344, Email: f.corrigan.1@research.gla.ac.uk) 
• Dr Liam Dorris, Chief Research Investigator and Consultant Paediatric 
Neuropsychologist, Fraser of Allander Neurosciences Unit (Tel: 0141 201 0863)
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Appendix 2.9 Parent Information Sheet 
     
 
Parent/ Guardian Information Sheet  
 
Learning and sleep in children and young people with epilepsy. 
 Researcher: Fiona Corrigan 
 
My name is Fiona Corrigan and I am a final year Trainee Clinical Psychologist at 
the University of Glasgow.  As part of my training I am carrying out research 
looking at the relationship between memory and sleep in children and young 
people with epilepsy.  This kind of research will hopefully improve our knowledge 
of the effects of epilepsy on children's learning.  
 
You and your child are being invited to take part in this study.  This leaflet provides 
information about the study.  If anything is not clear or you have any questions 
please do not hesitate to contact me (my contact details are at the end of the 
leaflet).  I have enclosed a child information sheet and would be grateful if you 
would read through this with your child. 
 
What is the purpose of this research? It has been found that some children with 
epilepsy forget information at a faster rate than those without epilepsy. Epilepsy 
can also have an effect on sleep. We would like to know whether there is a 
relationship between this type of forgetting and sleep in children and young people 
with epilepsy. This research will add to our knowledge of the factors that influence 
memory and  learning in children with epilepsy. In turn, this could lead to the 
development of interventions that could improve their learning.  
 
Why have we been chosen to take part? Children aged between 9 and 16 years 
old who have epilepsy and attend the Royal Hospital for Sick Children (Glasgow or 
Edinburgh) are being invited to take part in the study.  
 
Do I have to take part? No, it is up to you and your child whether or not you want 
to take part.  If you decide to take part you are both free to withdraw at any time 
without giving a reason.  A decision to withdraw or not to take part will not affect 
any on-going care.  
 
What will happen if my child and I agree to take part? 
If your child decides to take part you can contact me by phone, email or by 
returning the slip enclosed, in the stamped addressed envelope provided. Once 
you have indicated you and your child would like to participate I will contact you to 
arrange a suitable time and place to meet your child at Royal Hospital for Sick 
Children, Glasgow or Edinburgh. Before you and your child begin I will ask you to 
complete an Assent/Consent Form. I ask that you come along with your child to 
this meeting and I will issue you with the parent-completed questionnaires at the 
first appointment. 
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What will my child have to do? Taking part will involve two visits to the hospital. 
When I first meet your child I will explain what is involved to them and check that 
they are willing to take part. I will ask them to complete some short tasks to 
confirm we can proceed with the rest of the questions. I will then ask your child to 
complete two tasks related to their memory and ask them some questions. While 
your child is taking part, I will ask you to complete two parent questionnaires. 
These ask about your child’s sleep and memory. These questionnaires should 
take no longer than 20 minutes to complete. I will then explain to you and your 
child how to use the Actiwatch which is a wristwatch-like device that will record 
their sleep over a week long period. The watch is worn continuously and is water-
resistent.. It records and monitors movement, providing an estimate of sleep times 
based on periods of immobility. Actigraphy provides objective information on 
sleep-wake cycles in the participant's natural sleep environment.I will also give 
your child a questionnaire about their sleep to complete at home, which should 
take no longer than 10 minutes. This appointment should last approximately 1 
hour in total. I will ask you to return for a second short appointment with your child 
one week later. During this I will collect the Actiwatch and ask your child to 
complete some tasks related to their memory. This will take approximately 15 
minutes. You and your child’s participation in the study will begin at your first 
appointment and will end at your second appointment, eight days later.  
 
Are there risks or benefits to taking part? There are no risks to taking part.  
Your child will not be asked to take any medication or take part in any medical 
procedures. The information you and your child provide us with will help us to 
understand more about memory and sleep in children with epilepsy. The clinician 
who invited you to take part in the research may be informed of any relevant 
findings from the questionnaires.  
 
Will my taking part in the study be kept private? All information collected from 
you and your child will be kept strictly confidential.  Any information about them 
that is reported in the research will have all identifiable information like their name 
and address removed.  Only the researchers (myself, Dr Liam Dorris (Chief 
Research Investigator) and Andrew Morley (Respiratory Physiologist)) will have 
access to the information gathered as well as representatives of the study 
Sponsor, NHS GG&C, who may access information to make sure the study is 
being conducted properly.  All information will be stored in locked filing cabinets 
and a securely encrypted computer. As the initial tasks and memory tasks that 
your child will complete are routine clinical assessments, they will be stored 
securely in your child's clinical case notes and only be seen by NHS clinicians 
involved in their medical care. Case notes will not be accessed by the research 
team.  
 
What will happen to the results of the study? It is intended that the results will 
be published in my Doctoral thesis and a journal that specialises in epilepsy 
research.  You can obtain a copy of a lay summary by contacting me (Fiona 
Corrigan).  
 
Will the study help my child? 
This research could increase our understanding of how children with epilepsy 
learn and whether they might need extra educational support, for example, during 
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exams when there are more demands to learn new information. The medical and 
healthcare team could also benefit from understanding more about how having 
epilepsy can affect the education and learning of your child which may influence 
treatment and support decisions. 
 
Will my child be paid for taking part? 
No. Sorry, we cannot offer any payment or travel expenses.  
 
Who has reviewed this study? 
This study has been reviewed by the University of Glasgow, NHS Greater 
Glasgow and Clyde Research and Development Department and the North of 
Scotland Research Ethics Committee. 
 
For Further Information Please Contact:  
 
1) Fiona Corrigan, Trainee Clinical Psychologist, Department of Psychological 
Medicine, Gartnavel Royal Hospital (Tel: 07934157344, Email: 
f.corrigan.1@research.gla.ac.uk)  
 
2) Dr Liam Dorris, Consultant Paediatric Neuropsychologist, Fraser of Allander 
Neurosciences Unit (Tel: 0141 201 0863)  
 
If you would like to speak to someone impartial you can also contact Dr Helen 
Broome on 0141 201 0863 She is a Clinical Psychologist and researcher who 
works in Glasgow University but is not directly involved in thisresearch. She will be 
able to answer any questions you have. 
 
Thank you very much for taking the time to read this leaflet.  
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Appendix 2.10 Child Assent Form 
      
ASSENT FORM FOR CHILDREN 
(To be completed by the child and their parent/carer) 
  Learning and sleep in children and young people with epilepsy. 
Please circle Yes or No: 
 
Someone explained to me what the project is about. Yes/No 
 
I read and understood the information sheet and the explanation 
given to me. Yes/No 
 
I asked the researcher questions about the study if I didn’t know what 
something meant. Yes/No 
 
I know that I don’t have to take part in the project and that I can stop 
anytime I want to. Yes/No 
.  
I know that I will have to wear a special watch for a week to measure my sleep. Yes/No 
 
I know that my answers will be put into the study but no-one will know it was me because 
my name will not be in the study. Yes/No 
 
I would like to take part in this study. Yes/No      
 
If any answers are ‘no’ or you don’t want to take part, don’t sign your name!  
If you do want to take part, you can sign your name below  
Your name  ___________________________  
Signature       
Date   ___________________________  
The person who explained this project to you needs to sign too:  
Print Name  ___________________________  
Signature ___________________________  
Date   ___________________________    
Thank you for your help! 
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Appendix 2.11 Child Consent Form 
      
Young Person's Consent Form 
 
Learning and sleep in children and young people with epilepsy 
 
Institute of Health and Wellbeing, University of Glasgow, 1st floor, Administration Building, 
Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, G12 0XH  
 
The purpose of this form is to make sure that you are happy to take part in the research 
and that you know exactly what this involves. Thank you for agreeing to take part in our 
study investigating the relationship between memory and sleep in children with epilepsy.  
 
Subject number: 
   Please initial the BOX          Please initial box 
 
I confirm that I have read the information sheet dated 15/08/14 (Version 1) for the  
above study. 
 
I have had a chance to discuss this study and ask questions. 
 
I am happy with the answers given to all of my questions. 
 
I have been told enough about the study  
 
I agree for the data I provide to be recorded on a computer  and made anonymous,  
so that no one can tell it was me. 
 
I understand that this information will be kept securely so that only the research team and  
the people organising the study can see it. 
 
I agree for my data to be used in the final report, as long as it is anonymous 
 
I understand that my neurologist will be informed of my participation and any relevant  
findings from my participation.  
 
I understand that my participation is voluntary I am free to say no to taking part  
in this study at any time without having to give a reason and without affecting  
future medical care or legal rights 
 
I agree to take part in the above study 
 
 
---------------------------------------               -----------------         ---------------------------------- 
Name of Patient           Date      Signature 
 
 
---------------------------------------               -----------------          --------------------------------- 
Name of Person taking consent         Date       Signature 
 
 
 
1 copy to the patient, 1 copy to the researcher, 1 Original for the patients’ notes 
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Appendix 2.12 Parent Consent Form 
      
Parent/Guardian Consent Form 
 
Learning and sleep in children and young people with epilepsy 
 
Institute of Health and Wellbeing, University of Glasgow, 1st floor, Administration Building, 
Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, G12 0XH  
 
Thank you for agreeing to take part in our study. The purpose of this form is to make sure 
that you and your child are happy to take part in the research and that you know exactly 
what this involves. 
        Please initial box  
 
1. I confirm that my child and I have read and understood the information  
sheet dated 15/08/14 (Version 2) for the above study.  We have had the  
opportunity to ask questions about the study and we are happy with the  
answers provided.  
 
2. I understand that my participation and my child’s is voluntary and that  
we are free to withdraw at any time without giving a reason, without any  
medical care or rights being affected. 
 
3. I confirm that my child and I agree for the data we provide to be recorded  
on a computer or stored securely in a locked filing cabinet and made  
anonymous.  
 
4. I understand that my child's medical records and data may be looked at 
by representatives of the study Sponsor for audit purposes. 
 
5. I understand that my child's neurologist will be informed of participation and 
any relevant findings from my child's participation. They will be provided with 
some research task responses to store in your child's clinical case notes.  
 
6. I agree for my data to be used in the final report, as long as it is  
anonymous.  
 
7. I agree to myself and my child taking part in the above study, and my child  
agrees to take part. 
 
PLEASE COMPLETE: 
 
Name of Parent/Guardian……………………………………….Date………………  
Signature……………………………………………………………………………….   
 
Name of Child...........………………………………………………  
 
Name of Researcher………………………………………………Date……………..  
Signature………………………………………………………………………………            
 
1 copy to be retained by parent/carer and 1 copy to be retained by researcher 
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Appendix 2.13 Major Research Proposal 
 
Abstract 
 
Background: The phenomenon of accelerated long-term forgetting (ALF), in which 
newly acquired memories are intact after short delays but fade over days to weeks 
has recently been recognised in the paediatric epilepsy population. Given the well- 
established association between epilepsy and sleep disturbance and the evidence 
suggesting the importance of sleep in memory consolidation there is reason to 
investigate the relationship between ALF and sleep in children with epilepsy. 
 
Aims: This study aims to replicate previous findings and demonstrate the ALF 
phenomenon in children with Genetic Generalised Epilepsy (GGE). It will also 
investigate the relationship between ALF and behavioural sleep disturbance.  
 
Methods: Neuropsychological tests to assess ALF and objective and subjective 
measures of sleep will be used to explore the relationship between ALF and sleep.  
Correlation analysis will be used to determine whether poorer sleep is related to 
poorer initial learning and verbal memory recall.  
 
Applications: Findings from this study may improve our understanding of the ALF 
phenomenon and potentially underline the need for management of sleep 
problems in improving the learning of children with GGE. 
 
Introduction 
 
Clinically it has been observed that there is often a discrepancy between epilepsy 
patients' subjective report of memory abilities and their performance on 
neuropsychological tests of memory. An area researched in relation to this is the 
phenomenon of accelerated long-term forgetting (ALF), in which newly acquired 
memories are intact after short delays but fade over days to weeks. Relatively few 
group studies have been carried out in this area, and even fewer within the 
paediatric epilepsy population.  
 
Davidson, Dorris, O'Regan and Zuberi (2007) investigated whether children with 
idiopathic generalised epilepsy (IGE) demonstrated ALF for verbal and non-verbal 
information compared to matched controls after a one-week delay. Children with 
IGE required a greater number of learning trials to reach a learning criterion and 
displayed a significantly increased rate of forgetting compared with controls. 
Results indicated that poorer initial learning efficiency only impacted negatively on 
access to stored verbal information at the greater delay of one week, as there was 
no group difference at thirty-minute delay. The authors concluded that the IGE 
group's poorer recall at one week (i.e. ALF) was due to a problem with memory 
retrieval for verbal information rather than poor retention. Findings were not 
consistent with the consolidation theory i.e. that failure of consolidation leads to a 
failure of long term (neocortical) storage. Davidson et al.'s study serves to 
evidence that ALF exists in children with IGE.  
 
A similar study was carried out in 2012 by Gascoigne et al. Findings supported 
Davidson et al.'s (2007) results; children with IGE were found to recall fewer words 
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than controls after a week-long delay, but not thirty-minute delay. Conversely, their 
results were not explained by reduced learning efficiency as in the above study as 
there was no significant difference between the epilepsy group and controls in 
number of initial learning trials. Their findings were consistent with the 
consolidation theory. Although there is discrepancy between the two studies 
regarding the mechanisms underlying ALF, they are in agreement that it occurs in 
children with IGE.  
 
Most other research in the area has been undertaken with adults with temporal 
lobe epilepsy including the first report of ALF by Blake, Wroe, Breen and McCarthy 
(2000). Other studies have investigated the relationship between seizures, 
neuropathology and ALF (Muhlert et al. 2011; Mameniskiene, Jatuzis, Kaubrys & 
Budrys, 2006; Wilkinson et al., 2012). Whilst it is relatively uncontentious that a 
lifetime of temporal lobe seizures may affect learning and memory, the 
demonstration of these cognitive deficits in children with other epilepsy syndromes 
may have a significant role in planning education. 
 
Given the well-established association between epilepsy and sleep disturbance 
(Bazil, 2003; Becker, Fennell & Carney, 2003; Beran Plunket & Holland, 1999) and 
the evidence suggesting the importance of sleep in memory consolidation 
(Stickgold & Walker, 2007; Walker & Stickgold, 2004) there is reason to 
investigate the relationship between ALF and sleep in children with epilepsy. It is 
possible that sleep disturbance commonly experienced by children with epilepsy 
may affect their learning and explicit recall. Fitzgerald, Mohamed, Ricci, Thayer 
and Miller (2013a) discussed sleep as a potential contributing factor to ALF in 
epilepsy but highlighted that the limited existing evidence has produced mixed 
results. Fitzgerald, Thayer, Mohamed and Miller (2013b) tested recall for word and 
design lists at different delays, while patients with epilepsy underwent five days on 
continuous ambulatory EEG. Daytime naps were associated with better retention. 
Self-report of everyday memory functioning was related to recall at longer delays 
but not at thirty minutes, emphasising that standardised memory tests may fail to 
capture long-term recall abilities accurately.  
 
Walker and Stickgold (2004) reviewed the substantial body of evidence on sleep-
dependent learning and memory consolidation. Evidence is contradictory for the 
role of sleep in processing simple, emotion-free declarative memories, such as 
unrelated word pairs. A selective reminding test and actigraphy were used in a 
study by Deak, Stickgold, Pietras, Nelson and Bubrick (2011) examining how 
sleep impacts on the memory function of adults with TLE. People with TLE 
displayed greater forgetting compared to controls over twelve hours of daytime 
wakefulness but not over a similar period of sleep. The small sample size should 
be noted, along with the finding that there was no significant difference between 
TLE and control group on the objective or subjective measures of sleep. Slow 
wave sleep (SWS) was correlated with overnight performance change on the 
selective reminding test. Diekelmann, Wilhelm and Born (2009) also provide a 
review of studies in the area of sleep-dependent memory consolidation. Regarding 
children, those with high amounts of SWS post-learning had distinctly enhanced 
declarative memories.  
 
A review of the relationship between sleep and the effect on cognitive functioning 
in children with epilepsy discussed the influence of sleep disruption on seizures 
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and the neurophysiological and neurochemical mechanisms important for the 
memory–learning process (Parisi et al., 2010). It was concluded that improvement 
in the long-term cognitive–behavioural prognosis of children with epilepsy requires 
good sleep quality as well as good seizure control. 
 
Ashworth, Hill, Karmiloff-Smith and Dimitriou (2013) used actigraphy and novel 
learning tasks to investigate sleep-dependent memory consolidation in typically-
developing children. Recall performance improved significantly following a period 
of sleep but there was no change in score after a wake period. There was no 
statistically significant correlation between sleep quality or duration and initial or 
delayed task performance. All participants' sleep was within the normal range, 
perhaps explaining why they did not find a relationship between sleep 
quality/duration and performance on the learning tasks. Ashworth et al. (2013) 
suggest that future research compares memory consolidation and baseline 
performance in good and poor sleepers.  
 
One study to date has examined the relationship between memory consolidation 
and sleep in children with epilepsy. Sud et al. (2014) aimed to determine whether 
children with epilepsy were better able to consolidate memories after a sleep 
versus a wake period as has been demonstrated in typically developing children. 
Participants were presented word lists over five learning trials and recall was 
tested immediately and again after an average eleven hour delay. It was found 
that recall was significantly better after sleep, with results demonstrating a 
significant difference between memory consolidation and sleep versus wake trials 
for the majority of participants. However, this result was not found in the group 
analysis. Sud et al. (2014) used a small sample of children with epilepsy who had 
good sleep efficiency, which calls for further research to address these factors.  
 
Although the above two studies have investigated whether sleep improves 
memory consolidation in children, they compared sleep and wake periods with 
recall over periods no longer than twenty-four hours. The current proposed study 
will extend this investigation by analysing the relationship between sleep and ALF 
over a week long period in children with GGE.  
 
Aim 
 
This study aims to further investigate the phenomenon of ALF in children with 
Genetic Generalised Epilepsy (GGE).  
 
Hypotheses 
 
1)There will be a significant negative correlation between the number of learning 
trials it takes to learn the minimum criterion for the Stories and Word Lists tests 
and sleep efficiency. 
 
2) There will be a significant positive correlation between children's sleep 
efficiency and their recall for Stories and Word Lists tests after a delay of one 
week.  
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Participants 
 
This study will include twenty-seven children with GGE. GGE is the new 
terminology developed by the International League against Epilepsy that has 
replaced the disorders previously known as idiopathic generalised epilepsy (IGE) 
(Berg & Scheffer, 2011).  
 
Inclusion criteria include children and adolescents between the ages of 9-16 years 
who have a diagnosis of GGE and who speak English fluently. This age range was 
chosen as this is the age range the Children's Memory Scale (CMS) is 
standardised for. Exclusion criteria include: 1) individuals with a learning disability 
i.e. Full Scale IQ less than 70; 2) the presence of another major health or physical 
condition; 3) history of a neurological disorder other than epilepsy; 4) history of 
head injury 5) history of a specific sleep disorder and 6) history of psychiatric 
disorder.  
 
Recruitment 
 
All children with GGE who present at the epilepsy clinic or EEG department at the 
Fraser of Allander Neurosciences Unit at the Royal Hospital for Sick Children (who 
meet the inclusion criteria) will be identified by their Consultant Neurologist. If a 
potential participant is identified by the clinician at their first appointment with the 
service, information regarding the study will be handed to the young person and 
their parents/carer at their appointment. Study information will also be posted to all 
parents/carers of potential participants who attend for continuing care that are 
identified as meeting the inclusion criteria. 
 
Should they wish to participate, families will be asked to contact the main 
researcher either by returning the opt-in slip included with their invitation or by 
emailing or phoning. They will also indicate how they would prefer to be contacted 
to arrange a convenient time for the young person to attend for participation. 
Informed consent will be obtained from the young person and their parent/carer. 
 
If possible, research appointments will be scheduled for the same day as the 
young person’s next returning appointment to the clinic. 
 
From discussion with staff in the department, there is a large cohort of children 
with GGE who attend the epilepsy clinic. Davidson et al. (2007) were able to 
recruit their sample of twenty-one participants from the same site in a six-month 
period. If numbers were not available from RHSC Glasgow, it may be possible to 
supplement with recruitment from Edinburgh RHSC.   
 
Sample Size Justification 
 
An estimate of the sample size required for adequate statistical power was derived 
based on a study by Ashworth et al. (2013). This study was chosen as its design 
most closely resembles the one that will be used in the current study. From the 
results from the verbal memory task, it was calculated that there was a medium 
effect size (d=0.47). On this basis a medium effect size (d=0.50) was assumed, 
with the error value set at 0.05 and power at 0.80, for a power calculation (Cohen, 
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1992). The aim for recruitment is therefore to assess twenty-seven children with 
GGE.  
 
Measures 
 
The Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1999) will be 
used to measure IQ to ensure participants meet the inclusion criteria. In general, 
each subtest takes approximately 5 minutes to administer and the time taken to 
administer the entire battery is approximately 20 minutes.  
 
The Children’s Memory Scale (CMS) (Cohen, 1997) is a battery of nine subtests 
which assess children’s memory abilities. The Stories and Word Lists subtests will 
be used to assess participants’ verbal memory. The Stories test involves two short 
stories being read to the participant, who is then asked to repeat them verbatim. 
The stories will be administered in the same order to each participant. There are 
two sets of stories; use is dependent on the child's age, either the 9-12 or 13-16 
age groups. Participants will be required to learn two short stories to a level of 
90% accuracy (learning criterion), as set by Davidson et al. (2007). There will be a 
minimum of two learning trials, and up to a maximum of ten. Children who do not 
achieve the learning criterion within the maximum will be excluded from the study. 
Word Lists involve reading a list of 14 unrelated words to the participant who is 
then asked to recall as many items as possible. Items that have been missed are 
then repeated, and the participant again tries to recall the entire study list. 
Selective reminding of missed items will be provided for a maximum of ten 
learning trials until participants have reached 90% accuracy. Following the last 
learning trial, the participants' recall and recognition of the material will be tested 
after a thirty minute delay and then again after a one week delay. The recall and 
recognition scores for both stories will be combined to provide an overall score of 
recall and recognition respectively. The age appropriate versions of the subtests 
have different maximum total scores; therefore the delayed recall scores will be 
converted into z-scores to enable comparisons between the different versions. The 
CMS will take approximately 10-25 minutes to administer (depending on how 
many trial to criterion are required).  
 
Actigraphy will be used as an objective measure of participants' sleep. The 
actigraph is a nonintrusive device that records and monitors movement for one-
minute epochs through a wristwatch microprocessor link. It provides estimates of 
sleep and nap times based on periods of wrist immobility. Acebo et al. (1999) 
recommended that studies aiming to gather five nights of actigraph data for 
children and adolescents should record for at least one full week to ensure a 
reliable measurement is obtained. Five nights is adequate as a measure of sleep 
onset latency, number of awakenings, nocturnal restlessness and sleep efficiency. 
Participants will be set up with an actiwatch and given a sleep diary to complete 
when they complete the initial neuropsychological tests. This will take 
approximately 15 minutes.  
 
Seizure frequency, epilepsy status and epilepsy medication will be recorded over 
the testing period. This would require parents to provide this information. 
 
The Children's Sleep Habits Questionnaire (CSHQ) (Owens, Spirito & McGuinn, 
2000) will be used as a subjective parental report of sleep. Participants will also 
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complete the Sleep Self Report (SSR) (Owens, Maxim, Nobile, McGuinn, & Msall, 
2000). The Observer Memory Questionnaire - Parent Form (OMQ-PF) (Gonzalez 
et al., 2008) will be used as a subjective parental report of memory. These will 
each take 5-10 minutes to complete.  
 
Design 
 
A correlational design will be used to explore the relationship between ALF and 
sleep parameters.  
 
Procedures 
 
The WASI and subtests from the CMS will be administered. Recall and recognition 
will be assessed at a delay of thirty minutes after the last learning trial. During this 
delay participants and their parent/carer will be provided with information on how 
to use the actiwatches and complete the questionnaires. Participants will also be 
given a short break. Recall and recognition on the CMS will be tested again, seven 
days later. Actiwatches will be used to record sleep between the two 
recall/recognition time points (thirty minutes and seven days). Parents will 
complete sleep diaries, the CSHQ and OMQ-PF and participants will complete 
SSR for their return appointments. The CMS will take approximately 10 minutes 
and the main researcher will gather the actiwatch equipment and questionnaires 
and answer any questions the participants may have. The total time of the first 
appointment is estimated to be 60 minutes and 15 minutes for the return 
appointment.  
 
Data Analysis 
 
SPSS will be used for data analysis. Associations between variables will be 
examined using Pearson’s correlation for normally distributed variables and 
Spearman’s for non-normally distributed variables. Actiwatch data will be 
downloaded to a computer for analysis using the relevant software.  
 
Settings and equipment 
 
The study will take place at the Fraser of Allander Neurosciences Unit RHSC. 
There are approximately five actiwatches available from RHSC which could be 
used at any one time.  
 
Health and Safety Issues 
 
The study will be conducted within staffed settings during working hours. The 
researcher will comply with health and safety procedures of the department. The 
researcher will be present at all times and will remain vigilant to levels of client 
distress. Breaks will be provided as required by the participant. Participants will be 
informed that they can withdraw from the study at any time. 
 
Ethical Issues 
 
Ethical approval for this study will be sought from the NHS West of Scotland 
Research Ethics Service, the NHS GG&C R&D department, and from Glasgow 
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University Ethics Committee. Written consent will be obtained from participants 
and their parent/carer. Participants will be informed that they are free to leave the 
study at any point and that this will not affect any clinical treatment that they 
receive. Data will be coded and stored in accordance to NHS policies to ensure 
confidentiality.  
 
Financial Issues 
 
The overall cost of the study is estimated to be £213.86.  
 
Timetable 
 
Full Proposal for examination    April 2014 
Ethics and R&D submission    June 2014 
Participant recruitment    October 2014-May 
2015 
Data analysis    May 2015 
Penultimate draft (final paper)    June 2015 
Final draft    July 2015 
 
Practical Applications 
 
The findings from this study will enhance our understanding of the ALF 
phenomenon in children with epilepsy. Determining whether sleep influences ALF 
in children with epilepsy will have practical applications for their learning. As 
children with epilepsy are known to perform poorer academically than their 
typically developing peers, any knowledge of how their learning could be improved 
is helpful. Data gathered can be used to design appropriate and effective 
psychological and educational interventions for children with epilepsy. The findings 
will encourage and inform future research in this area.  
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